Selected Publications

  1. Abou Ezzeddine OF, Kemp BJ, Borlaug BA, Mullan BP, Behfar A, Pislaru SV, Fudim M, Redfield MM, Chareonthaitawee P: Myocardial Energetics in Heart Failure With Preserved Ejection Fraction. Circulation: Heart Failure 2019, 12(10):e006240.
  2. Ahlstedt J, Johansson E, Sydoff M, Karlsson H, Thordarsson E, Gram M, Eriksson O: Non-invasive imaging methodologies for assessment of radiation damage to bone marrow and kidneys from peptide receptor radionuclide therapy. Neuroendocrinology 2019.
  3. Ahmed H, Haider A, Varisco J, Stanković M, Wallimann R, Gruber S, Iten I, Häne S, Müller Herde A, Keller C: Structure–Affinity Relationships of 2, 3, 4, 5-Tetrahydro-1 H-3-benzazepine and 6, 7, 8, 9-Tetrahydro-5 H-benzo [7] annulen-7-amine Analogues and the Discovery of a Radiofluorinated 2, 3, 4, 5-Tetrahydro-1 H-3-benzazepine Congener for Imaging GluN2B Subunit-Containing N-Methyl-d-aspartate Receptors. Journal of medicinal chemistry 2019, 62(21):9450-9470.
  4. Akamatsu G, Tashima H, Iwao Y, Wakizaka H, Maeda T, Yoshida E, Yamaya T: A 3-dimensional hemispherical brain phantom for compact dedicated brain PET scanners. Biomedical Physics & Engineering Express 2019, 5(2):025013.
  5. Albrecht DS, Forsberg A, Sandström A, Bergan C, Kadetoff D, Protsenko E, Lampa J, Lee YC, Höglund CO, Catana C: Brain glial activation in fibromyalgia–A multi-site positron emission tomography investigation. Brain, behavior, and immunity 2019, 75:72-83.
  6. Allen KJ, Jiao R, Malo ME, Frank C, Fisher DR, Rickles D, Dadachova E: Comparative Radioimmunotherapy of Experimental Melanoma with Novel Humanized Antibody to Melanin Labeled with 213Bismuth and 177Lutetium. Pharmaceutics 2019, 11(7):348.
  7. Ametamey SM: Ketamine and Ceftriaxone-Induced Alterations in Glutamate Levels Do Not Impact the Specific Binding of Metabotropic Glutamate Receptor Subtype 5 Radioligand [18F] PSS232 in the Rat Brain. Targets, Tracers and Translation–Novel Radiopharmaceuticals Boost Nuclear Medicine 2019, 11:84.
  8. Avendaño-Estrada A, Velasco F, Velasco AL, Cuellar-Herrera M, Saucedo-Alvarado PE, Marquez-Franco R, Rivera-Bravo B, Ávila-Rodríguez MA: Quantitative Analysis of [18F] FFMZ and [18F] FDG PET Studies in the Localization of Seizure Onset Zone in Drug-Resistant Temporal Lobe Epilepsy. Stereotactic and functional neurosurgery 2019, 97(4):232-240.
  9. Avendaño-Estrada A, Velasco-Campos F, Carrillo-Ruiz J, Ávila-Rodríguez M: On the use of quantitative PET imaging to study human brain in healthy controls and epileptic patients: A 18FGD and 18FMMZ study. In: AIP Conference Proceedings: 2019: AIP Publishing; 2019: 030001.
  10. Bailey JJ, Kaiser L, Lindner S, Wüst M, Thiel A, Soucy J-P, Rosa-Neto P, Scott PJ, Unterrainer M, Kaplan DR: First-in-Human Brain Imaging of [18F] TRACK, a PET tracer for Tropomyosin Receptor Kinases. ACS chemical neuroscience 2019, 10(6):2697-2702.
  11. Baldinger-Melich P, Gryglewski G, Philippe C, James GM, Vraka C, Silberbauer L, Balber T, Vanicek T, Pichler V, Unterholzner J: The effect of electroconvulsive therapy on cerebral monoamine oxidase A expression in treatment-resistant depression investigated using positron emission tomography. Brain stimulation 2019.
  12. Bascuñana P, García-García L, Javela J, de la Rosa RF, Shiha AA, Kelly J, Delgado M, Pozo MÁ: PET Neuroimaging Reveals Serotonergic and Metabolic Dysfunctions in the Hippocampal Electrical Kindling Model of Epileptogenesis. Neuroscience 2019, 409:101-110.
  13. Bascuñana P, Gendron T, Sander K, Jahreis I, Polyak A, Ross TL, Bankstahl M, Arstad E, Bankstahl JP: Ex vivo characterization of neuroinflammatory and neuroreceptor changes during epileptogenesis using candidate positron emission tomography biomarkers. Epilepsia 2019.
  14. Bascuñana P, Heß A, Borchert T, Wang Y, Wollert KC, Bengel FM, Thackeray JT: 11C-Methionine PET Identifies Astroglia Involvement in Heart-Brain Inflammation Networking after Acute Myocardial Infarction. Journal of Nuclear Medicine 2019:jnumed. 119.236885.
  15. Bascuñana P, Thackeray JT, Bankstahl M, Bengel FM, Bankstahl JP: Anesthesia and Preconditioning Induced Changes in Mouse Brain [18 F] FDG Uptake and Kinetics. Molecular Imaging and Biology 2019:1-8.
  16. Bastin C, Bahri MA, Meyer F, Manard M, Delhaye E, Plenevaux A, Becker G, Seret A, Mella C, Giacomelli F: In vivo imaging of synaptic loss in Alzheimer’s disease with [18F] UCB-H Positron Emission Tomography. European journal of nuclear medicine and molecular imaging 2019:1-13.
  17. Bauman MD, Lesh TA, Rowland DJ, Schumann CM, Smucny J, Kukis DL, Cherry SR, McAllister AK, Carter CS: Preliminary evidence of increased striatal dopamine in a nonhuman primate model of maternal immune activation. Translational psychiatry 2019, 9(1):135.
  18. Becker G, Lespine L-F, Bahri MA, Serrano ME, Lemaire C, Luxen A, Tirelli E, Plenevaux A: Neuro-functional correlates of protective effects of wheel-running exercise against cocaine locomotor sensitization in mice: a [18F] fallypride microPET study. bioRxiv 2019:855791.
  19. Bellaver B, da Rocha AS, Souza DG, Leffa DT, De Bastiani MA, Schu G, Ferreira PCL, Venturin GT, Greggio S, Ribeiro CT: Activated peripheral blood mononuclear cell mediators trigger astrocyte reactivity. Brain, behavior, and immunity 2019, 80:879-888.
  20. Benz DC, Ferro P, Safa N, Messerli M, von Felten E, Huang W, Patriki D, Giannopoulos AA, Fuchs TA, Grani C et al: Role of quantitative myocardial blood flow and (13)N-ammonia washout for viability assessment in ischemic cardiomyopathy. J Nucl Cardiol 2019.
  21. Benz DC, Gräni C, Ferro P, Neumeier L, Messerli M, Possner M, Clerc OF, Gebhard C, Gaemperli O, Pazhenkottil AP: Corrected coronary opacification decrease from coronary computed tomography angiography: validation with quantitative 13N-ammonia positron emission tomography. Journal of Nuclear Cardiology 2019, 26(2):561-568.
  22. Benz DC, von Dahlen AP, Huang W, Messerli M, von Felten E, Benetos G, Giannopoulos AA, Fuchs TA, Gräni C, Gebhard C: No differences in rest myocardial blood flow in stunned and hibernating myocardium: insights into the pathophysiology of ischemic cardiomyopathy. European journal of nuclear medicine and molecular imaging 2019, 46(11):2322-2328.
  23. Berroterán-Infante N, Kalina T, Fetty L, Janisch V, Velasco R, Vraka C, Hacker M, Haug AR, Pallitsch K, Wadsak W: (R)-[18F] NEBIFQUINIDE: A promising new PET tracer for TSPO imaging. European journal of medicinal chemistry 2019.
  24. Bertoglio D, Verhaeghe J, Miranda A, Kertesz I, Cybulska K, Korat Š, Wyffels L, Stroobants S, Mrzljak L, Dominguez C: Validation and noninvasive kinetic modeling of [11C] UCB-J PET imaging in mice. Journal of Cerebral Blood Flow & Metabolism 2019:0271678X19864081.
  25. Beyer L, Schnabel J, Kazmierczak P, Ewers M, Schönecker S, Prix C, Meyer-Wilmes J, Unterrainer M, Catak C, Pogarell O: Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer’s disease. NeuroImage: Clinical 2019, 24:101949.
  26. Beziere N, Fuchs K, Maurer A, Reischl G, Brück J, Ghoreschi K, Fehrenbacher B, Berrio DC, Schenke-Layland K, Kohlhofer U: Imaging fibrosis in inflammatory diseases: targeting the exposed extracellular matrix. Theranostics 2019, 9(10):2868.
  27. Biegon A, Shroyer KR, Franceschi D, Dhawan J, Tahmi M, Pareto D, Bonilla P, Airola K, Cohen J: Initial studies with [11C] vorozole positron emission tomography detect over-expression of intra-tumoral aromatase in breast cancer. Journal of Nuclear Medicine 2019:jnumed. 119.231589.
  28. Billington S, Shoner S, Lee S, Clark-Snustad K, Pennington M, Lewis D, Muzi M, Rene S, Lee J, Nguyen TB: Positron Emission Tomography Imaging of [11 C] Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporin A. Clinical pharmacology and therapeutics 2019, 106(5):1056-1066.
  29. Billington S, Shoner S, Lee S, Clark-Snustad K, Pennington M, Lewis D, Muzi M, Rene S, Lee J, Nguyen TB: PET Imaging of [11C] Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporine A. Clinical Pharmacology & Therapeutics 2019.
  30. Bohórquez SS, Marik J, Ogasawara A, Tinianow JN, Gill HS, Barret O, Tamagnan G, Alagille D, Ayalon G, Manser P: [18 F] GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging 2019, 46(10):2077-2089.
  31. Bolaños-Puchet S: xgrid3d: A free software tool for quantitative image analysis and internal dosimetry. In: AIP Conference Proceedings: 2019: AIP Publishing; 2019: 030003.
  32. Bonaventura J, Eldridge MA, Hu F, Gomez JL, Sanchez-Soto M, Abramyan AM, Lam S, Boehm MA, Ruiz C, Farrell MR: High-potency ligands for DREADD imaging and activation in rodents and monkeys. Nature communications 2019, 10(1):1-12.
  33. Borelli WV, Leal-Conceiao E, Andrade MA, Esper NB, Feltes PK, Soder RB, Matushita CS, Hartmann LM, Radaelli G, Schilling LP: Neural correlates of exceptional memory ability in SuperAgers: A multimodal approach using FDG-PET, PIB-PET, and MRI. bioRxiv 2019:666438.
  34. Brendel M, Deussing M, Blume T, Kaiser L, Probst F, Overhoff F, Peters F, von Ungern-Sternberg B, Ryazanov S, Leonov A: Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer’s disease tau. Alzheimer’s research & therapy 2019, 11(1):67.
  35. Brown D, Sarkar G, Decklever T, Curran G, Sarkar A: K16ApoE Enhances Aβ-associated 11C-PiB Deposition and PET Signal in APP/PS1 Transgenic Mice. J Alzheimers Dis Parkinsonism 2019, 9(468):2.
  36. Brown EE, Rashidi-Ranjbar N, Caravaggio F, Gerretsen P, Pollock BG, Mulsant BH, Rajji TK, Fischer CE, Flint A, Mah L et al: Brain Amyloid PET Tracer Delivery is Related to White Matter Integrity in Patients with Mild Cognitive Impairment. J Neuroimaging 2019, 29(6):721-729.
  37. Brugnolo A, De Carli F, Pagani M, Morbelli S, Jonsson C, Chincarini A, Frisoni GB, Galluzzi S, Perneczky R, Drzezga A: Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer’s Disease. Journal of Alzheimer’s Disease 2019(Preprint):1-12.
  38. Brumberg J, Tran-Gia J, Lapa C, Isaias IU, Samnick S: PET imaging of noradrenaline transporters in Parkinson’s disease: focus on scan time. Annals of nuclear medicine 2019, 33(2):69-77.
  39. Buchert R, Lange C, Spehl TS, Apostolova I, Frings L, Jonsson C, Meyer PT, Hellwig S: Diagnostic performance of the specific uptake size index for semi-quantitative analysis of I-123-FP-CIT SPECT: harmonized multi-center research setting versus typical clinical single-camera setting. EJNMMI research 2019, 9(1):37.
  40. Buchsbaum MS, DeCastro A: Positron Emission Tomography and Computed Tomography Measurement of Brown Fat Thermal Activation: Key Tool for Developing Novel Pharmacotherapeutics for Obesity and Diabetes. In: Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. edn.: Springer, Cham; 2019: 191-210.
  41. Bui DV, Kanda A, Kobayashi Y, Sakata Y, Kono Y, Kamakura Y, Jinno T, Yun Y, Suzuki K, Sawada S: A Novel Approach for Investigating Upper Airway Hyperresponsiveness Using Micro-CT in Eosinophilic Upper Airway Inflammation such as Allergic Rhinitis Model. Biomolecules 2019, 9(7):252.
  42. Bullich S, Barret O, Constantinescu C, Sandiego C, Mueller A, Berndt M, Papin C, Perrotin A, Koglin N, Kroth H: Evaluation of dosimetry, quantitative methods and test-retest variability of 18F-PI-2620 PET for the assessment of tau deposits in the human brain. Journal of Nuclear Medicine 2019:jnumed. 119.236240.
  43. Burley TA, Da Pieve C, Martins CD, Ciobota DM, Allott L, Oyen WJ, Harrington KJ, Smith G, Kramer-Marek G: Affibody-based PET imaging to guide EGFR-targeted cancer therapy in head and neck squamous cell cancer models. Journal of Nuclear Medicine 2019, 60(3):353-361.
  44. Büther F, Seifert R, Backhaus P, Schäfers M: Einfluss der Detektorsensitivität eines Blutsamplers auf die kinetische Modellierung von PET-Daten: Ergebnisse einer numerischen Simulationsstudie. Nuklearmedizin 2019, 58(02):P114.
  45. Cai M, Lee J-H, Yang EJ: Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer’s disease animal model. Journal of Neuroinflammation 2019, 16(1):1-12.
  46. Cai N-S, Quiroz C, Bonaventura J, Bonifazi A, Cole TO, Purks J, Billing AS, Massey E, Wagner M, Wish ED: Opioid–galanin receptor heteromers mediate the dopaminergic effects of opioids. The Journal of clinical investigation 2019, 129(7).
  47. Cai X, Zhang K, Xie X, Zhu X, Feng J, Jin Z, Zhang H, Tian M, Chen H: Self-assembly hollow manganese Prussian white nanocapsules attenuate Tau-related neuropathology and cognitive decline. Biomaterials 2019, 231:119678.
  48. Cao Q, Huang Q, Mohan C, Li C: μPET/CT imaging of local and systemic immune response using 64Cu-αCD11b. Journal of Nuclear Medicine 2019:jnumed. 118.220350.
  49. Cao Y, Gathaiya N, Han Q, Kemp BJ, Jensen MD: Subcutaneous Adipose Tissue Free Fatty Acid Uptake Measured Using Positron Emission Tomography and Adipose Biopsies in Humans. American Journal of Physiology-Endocrinology and Metabolism 2019.
  50. Carvalho RH, Real CC, Cinini S, Garcez AT, Duran FL, Marques FL, Mello LE, Busatto Filho G, de Vries EF, de Britto LR: [11C] PIB PET imaging can detect white and grey matter demyelination in a non-human primate model of progressive multiple sclerosis. Multiple sclerosis and related disorders 2019, 35:108-115.
  51. Castaño-Castaño S, Feijoo-Cuaresma M, Paredes-Pacheco J, Morales-Navas M, Ruiz-Guijarro J, Sanchez-Santed F, Nieto-Escámez F: tDCS recovers depth perception in adult amblyopic rats and reorganizes visual cortex activity. Behavioural brain research 2019, 370:111941.
  52. Castellano C-A, Hudon C, Croteau E, Fortier M, St-Pierre V, Vandenberghe C, Nugent S, Tremblay S, Paquet N, Lepage M: Links Between Metabolic and Structural Changes in the Brain of Cognitively Normal Older Adults: A 4-Year Longitudinal Follow-Up. Frontiers in aging neuroscience 2019, 11.
  53. Castrellon JJ, Young JS, Dang LC, Cowan RL, Zald DH, Samanez-Larkin GR: Mesolimbic dopamine D2 receptors and neural representations of subjective value. Scientific Reports 2019, 9(1):1-12.
  54. Ceccarini J, Ahmad R, Van de Vliet L, Casteels C, Vandenbulcke M, Vandenberghe W, Van Laere K: Behavioral symptoms in premanifest Huntington disease correlate with reduced frontal CB1R levels. Journal of Nuclear Medicine 2019, 60(1):115-121.
  55. Ceccarini J, Casteels C, Ahmad R, Crabbé M, Van de Vliet L, Vanhaute H, Vandenbulcke M, Vandenberghe W, Van Laere K: Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson’s disease. European journal of nuclear medicine and molecular imaging 2019, 46(11):2348-2357.
  56. Ceccarini J, Leurquin-Sterk G, Crunelle C, de Laat B, Bormans G, Peuskens H, Van Laere K: Recovery of decreased metabotropic glutamate receptor 5 availability in abstinent alcohol-dependent patients. Journal of Nuclear Medicine 2019:jnumed. 119.228825.
  57. Chan K, Robert F, Oertlin C, Kapeller-Libermann D, Avizonis D, Gutierrez J, Handly-Santana A, Doubrovin M, Park J, Schoepfer C: eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma. Nature communications 2019, 10(1):1-16.
  58. Chang Y-J, Ho C-L, Cheng K-H, Kuo W-I, Lee W-C, Lan K-L, Chang C-H: Biodistribution, pharmacokinetics and radioimmunotherapy of 188 Re-cetuximab in NCI-H292 human lung tumor-bearing nude mice. Investigational new drugs 2019:1-12.
  59. Chen Y, Goorden MC, Vastenhouw B, Beekman FJ: Optimized sampling for high resolution multi-pinhole brain SPECT with stationary detectors. Physics in Medicine & Biology 2019.
  60. Chen Y-H, Chang K-P, Chu S-C, Yen T-C, Wang L-Y, Chang JT-C, Hsu C-L, Ng S-H, Liu S-H, Chan S-C: Value of early evaluation of treatment response using 18 F-FDG PET/CT parameters and the Epstein-Barr virus DNA load for prediction of outcome in patients with primary nasopharyngeal carcinoma. European journal of nuclear medicine and molecular imaging 2019, 46(3):650-660.
  61. Chen Y-H, Lue K-H, Chu S-C, Chang B-S, Wang L-Y, Liu D-W, Liu S-H, Chao Y-K, Chan S-C: Combining the radiomic features and traditional parameters of 18 F-FDG PET with clinical profiles to improve prognostic stratification in patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and surgery. Annals of Nuclear Medicine 2019:1-14.
  62. Cheng M-F, Huang Y-Y, Ho B-Y, Kuo T-C, Hsin L-W, Shiue C-Y, Kuo H-C, Jeng Y-M, Yen R-F, Tien Y-W: Prospective comparison of (4S)-4-(3-18 F-fluoropropyl)-l-glutamate versus 18 F-fluorodeoxyglucose PET/CT for detecting metastases from pancreatic ductal adenocarcinoma: a proof-of-concept study. European journal of nuclear medicine and molecular imaging 2019:1-11.
  63. Chiu C-C, Lu C-S, Weng Y-H, Chen Y-L, Huang Y-Z, Chen R-S, Cheng Y-C, Huang Y-C, Liu Y-C, Lai S-C: PARK14 (D331Y) PLA2G6 causes early-onset degeneration of substantia nigra dopaminergic neurons by inducing mitochondrial dysfunction, ER stress, mitophagy impairment and transcriptional dysregulation in a knockin mouse model. Molecular neurobiology 2019, 56(6):3835-3853.
  64. Chu Y, Muller S, Tavares A, Barret O, Alagille D, Seibyl J, Tamagnan G, Marek K, Luk KC, Trojanowski JQ: Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes. Brain 2019, 142(11):3565-3579.
  65. Chung Y-H, Yu C-F, Chiu S-C, Chiu H, Hsu S-T, Wu C-R, Yang C-L, Hong J-H, Yen T-C, Chen F-H: Diffusion-weighted MRI and 18 F-FDG PET correlation with immunity in early radiotherapy response in BNL hepatocellular carcinoma mouse model: timeline validation. European journal of nuclear medicine and molecular imaging 2019:1-12.
  66. Cicone F, Gnesin S, Denoël T, Stora T, van der Meulen NP, Müller C, Vermeulen C, Benešová M, Köster U, Johnston K: Internal radiation dosimetry of a 152 Tb-labeled antibody in tumor-bearing mice. EJNMMI research 2019, 9(1):53.
  67. Cil O, Anderson MO, Yen R, Kelleher B, Huynh TL, Seo Y, Nilsen SP, Turner JR, Verkman AS: Slowed gastric emptying and improved oral glucose tolerance produced by a nanomolar-potency inhibitor of calcium-activated chloride channel TMEM16A. The FASEB Journal 2019, 33(10):11247-11257.
  68. Constantinescu CC, Tresse C, Zheng M, Gouasmat A, Carroll VM, Mistico L, Alagille D, Sandiego CM, Papin C, Marek K: Development and in vivo preclinical imaging of fluorine-18-labeled synaptic vesicle protein 2A (SV2A) PET tracers. Molecular Imaging and Biology 2019, 21(3):509-518.
  69. Corral A, López R, Balcerzyk M, Parrado-Gallego A, Fernández-Gómez I, Olmo A, Risco R: Use of X-Ray Computed Tomography for Ice Detection Applied to Organ Cryopreservation. Biopreservation and biobanking 2019, 17(2):119-128.
  70. Coughlin JM, Du Y, Crawford JL, Rubin LH, Azad BB, Lesniak WG, Horti AG, Schretlen DJ, Sawa A, Pomper MG: Use of 18F-ASEM PET to Determine the Availability of the α7-Nicotinic Acetylcholine Receptor in Recent-Onset Psychosis. Journal of Nuclear Medicine 2019, 60(2):241-243.
  71. Crabbé M, Dirkx N, Casteels C, Van Laere K: Excitotoxic neurodegeneration is associated with a focal decrease in metabotropic glutamate receptor type 5 availability: an in vivo PET imaging study. Scientific reports 2019, 9(1):1-10.
  72. Crabbé M, Van der Perren A, Kounelis S, Lavreys T, Bormans G, Baekelandt V, Casteels C, Van Laere K: Temporal changes in neuroinflammation and brain glucose metabolism in a rat model of viral vector-induced α-synucleinopathy. Experimental neurology 2019, 320:112964.
  73. da Cunha-Bang S, Ettrup A, Mc Mahon B, Skibsted AP, Schain M, Lehel S, Dyssegaard A, Jørgensen LM, Møller K, Gillings N: Measuring endogenous changes in serotonergic neurotransmission with [11 C] Cimbi-36 positron emission tomography in humans. Translational psychiatry 2019, 9(1):134.
  74. Dagnino APA, da Silva RBM, Chagastelles PC, Pereira TCB, Venturin GT, Greggio S, da Costa JC, Bogo MR, Campos MM: Nociceptin/orphanin FQ receptor modulates painful and fatigue symptoms in a mouse model of fibromyalgia. Pain 2019, 160(6):1383-1401.
  75. Dahlsson Leitao C, Rinne SS, Mitran B, Vorobyeva A, Andersson KG, Tolmachev V, Ståhl S, Löfblom J, Orlova A: Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of 68Ga-Labeled Tracers. International journal of molecular sciences 2019, 20(5):1080.
  76. Dávalos-Salas M, Montgomery MK, Reehorst CM, Nightingale R, Ng I, Anderton H, Al-Obaidi S, Lesmana A, Scott CM, Ioannidis P: Deletion of intestinal Hdac3 remodels the lipidome of enterocytes and protects mice from diet-induced obesity. Nature communications 2019, 10(1):1-14.
  77. De Bruycker S, Vangestel C, Staelens S, Detrez J, Verschuuren M, De Vos WH, Pauwels P, Van den Wyngaert T, Stroobants S: Effects of metformin on tumor hypoxia and radiotherapy efficacy: a [18 F] HX4 PET imaging study in colorectal cancer xenografts. EJNMMI research 2019, 9(1):74.
  78. De Bruycker S, Vangestel C, Van den Wyngaert T, Pauwels P, Staelens S, Stroobants S: 18F-flortanidazole hypoxia PET holds promise as a prognostic and predictive imaging biomarker in a lung cancer xenograft model treated with metformin and radiotherapy. Journal of Nuclear Medicine 2019, 60(1):34-40.
  79. De Carli F, Nobili F, Pagani M, Bauckneht M, Massa F, Grazzini M, Jonsson C, Peira E, Morbelli S, Arnaldi D: Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease. European journal of nuclear medicine and molecular imaging 2019, 46(2):334-347.
  80. de Laat B, Weerasekera A, Leurquin-Sterk G, Gsell W, Bormans G, Himmelreich U, Casteels C, Van Laere K: Effects of alcohol exposure on the glutamatergic system: a combined longitudinal 18F-FPEB and 1H-MRS study in rats. Addiction biology 2019, 24(4):696-706.
  81. De Leo TC, dos Santos SN, Andrade CDC, Ricci E, Turato WM, Lopes NP, Oliveira RS, Bernardes ES, Dias-Baruffi M: Engineering of galectin-3 for glycan-binding optical imaging. Biochemical and biophysical research communications 2019, 521(3):674-680.
  82. De Lombaerde S, Devisscher L, Verhoeven J, Neyt S, Van Vlierberghe H, Vanhove C, De Vos F: Validation of hepatobiliary transport PET imaging in liver function assessment: Evaluation of 3β-[18F] FCA in mouse models of liver disease. Nuclear medicine and biology 2019, 68:40-48.
  83. De Lombaerde S, Neyt S, Vanhove C, De Vos F: In Vivo Measurement of Hepatic Drug Transporter Inhibition with Radiolabeled Bile Acids. In: Experimental Cholestasis Research. edn.: Springer; 2019: 87-98.
  84. De Picker L, Ottoy J, Verhaeghe J, Deleye S, Fransen E, Kosten L, Sabbe B, Coppens V, Timmers M, de Boer P: State-associated changes in longitudinal [18F]-PBR111 TSPO PET imaging of psychosis patients: Evidence for the accelerated ageing hypothesis? Brain, behavior, and immunity 2019, 77:46-54.
  85. Delgado H, Agrati D, Machado L, Reyes L, Savio E, Engler H, Ferreira A: Cocaine treatment before pregnancy differentially affects the anxiety and brain glucose metabolism of lactating rats if performed during adulthood or adolescence. Behavioural brain research 2019, 372:112070.
  86. Delva A, Van Weehaeghe D, van Aalst J, Ceccarini J, Koole M, Baete K, Nuyts J, Vandenberghe W, Van Laere K: Quantification and discriminative power of 18 F-FE-PE2I PET in patients with Parkinson’s disease. European journal of nuclear medicine and molecular imaging 2019:1-14.
  87. Di Ciano P, Mansouri E, Tong J, Wilson AA, Houle S, Boileau I, Duvauchelle T, Robert P, Schwartz JC, Le Foll B: Occupancy of dopamine D 2 and D 3 receptors by a novel D3 partial agonist BP1. 4979: a [11 C]-(+)-PHNO PET study in humans. Neuropsychopharmacology 2019, 44(7):1284.
  88. Dmochowska N, Tieu W, Keller MD, Wardill HR, Mavrangelos C, Campaniello MA, Takhar P, Hughes PA: Immuno-PET of Innate Immune Markers CD11b and IL-1β Detects Inflammation in Murine Colitis. Journal of Nuclear Medicine 2019, 60(6):858-863.
  89. Donovan L, Magnussen J, Dyssegaard A, Lehel S, Hooker J, Knudsen G, Hansen H: Imaging HDACs In Vivo: Cross-Validation of the [11 C] Martinostat Radioligand in the Pig Brain. Molecular imaging and biology 2019:1-9.
  90. Drescher R, Gühne F, Seifert P, Kühnel C, Freesmeyer M: Ex Vivo Evaluation of Residual Activity and Infusion Dynamics in a Commercially Available Yttrium-90 Resin Microsphere Administration System. Journal of Vascular and Interventional Radiology 2019, 30(9):1504-1511.
  91. Dubol M, Trichard C, Leroy C, Granger B, Tzavara ET, Martinot J-L, Artiges E: Lower midbrain dopamine transporter availability in depressed patients: Report from high-resolution PET imaging. Journal of affective disorders 2019, 262:273-277.
  92. Dyke JP, Garfinkel JH, Volpert L, Sanders A, Newcomer M, Dutruel SP, Sofka CM, Ellis SJ, Demetracopoulos CA: Imaging of Bone Perfusion and Metabolism in Subjects Undergoing Total Ankle Arthroplasty Using 18F-Fluoride Positron Emission Tomography. Foot & ankle international 2019:1071100719882717.
  93. Ebert SE, Jensen P, Ozenne B, Armand S, Svarer C, Stenbaek DS, Moeller K, Dyssegaard A, Thomsen G, Steinmetz J: Molecular imaging of neuroinflammation in patients after mild traumatic brain injury: a longitudinal 123I-CLINDE SPECT study. European journal of neurology 2019.
  94. Elmi A, Makvandi M, Weng C-C, Hou C, Clark AS, Mach RH, Mankoff DA: Cell-proliferation imaging for monitoring response to CDK4/6 inhibition combined with endocrine-therapy in breast cancer: Comparison of [18F] FLT and [18F] ISO-1 PET/CT. Clinical Cancer Research 2019, 25(10):3063-3073.
  95. Elvas F, Berghe TV, Adriaenssens Y, Vandenabeele P, Augustyns K, Staelens S, Stroobants S, Van der Veken P: Caspase-3 probes for PET imaging of apoptotic tumor response to anticancer therapy. Organic & biomolecular chemistry 2019, 17(19):4801-4824.
  96. Endo H, Shimada H, Sahara N, Ono M, Koga S, Kitamura S, Niwa F, Hirano S, Kimura Y, Ichise M: In vivo binding of a tau imaging probe,[11C] PBB3, in patients with progressive supranuclear palsy. Movement Disorders 2019.
  97. Erdmann S, Niederstadt L, Koziolek EJ, Gómez JDC, Prasad S, Wagener A, von Hacht JL, Hallmann S, Exner S, Bandholtz S: CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer. bioRxiv 2019, 9(22):575902.
  98. Eriksen PL, Thomsen KL, Larsen LP, Grønbæk H, Vilstrup H, Sørensen M: Non-alcoholic steatohepatitis, but not simple steatosis, disturbs the functional homogeneity of the liver–a human galactose positron emission tomography study. Alimentary pharmacology & therapeutics 2019.
  99. Eriksson J, Roy T, Sawadjoon S, Bachmann K, Sköld C, Larhed M, Weis J, Selvaraju RK, Korsgren O, Eriksson O: Synthesis and preclinical evaluation of the CRTH2 antagonist [11C] MK-7246 as a novel PET tracer and potential surrogate marker for pancreatic beta-cell mass. Nuclear medicine and biology 2019, 71:1-10.
  100. Eriksson O, Selvaraju RK, Berglund M, Espes D: Metabolically Active Brown Adipose Tissue Is Found in Adult Subjects with Type 1 Diabetes. International journal of molecular sciences 2019, 20(23):5827.
  101. Eriksson O, Velikyan I, Haack T, Bossart M, Evers A, Laitinen I, Larsen PJ, Plettenburg O, Takano A, Halldin C: Assessment of glucagon receptor occupancy by positron emission tomography in non-human primates. Scientific reports 2019, 9(1):1-11.
  102. Escudero-Castellanos A, Ocampo-García B, Ferro-Flores G, Santos-Cuevas C, Morales-Ávila E, Luna-Gutiérrez M, Isaac-Olivé K: Synthesis and preclinical evaluation of the 177Lu-DOTA-PSMA (inhibitor)-Lys3-bombesin heterodimer designed as a radiotheranostic probe for prostate cancer. Nuclear medicine communications 2019, 40(3):278-286.
  103. Espes D, Manell E, Rydén A, Carlbom L, Weis J, Jensen-Waern M, Jansson L, Eriksson O: Pancreatic perfusion and its response to glucose as measured by simultaneous PET/MRI. Acta diabetologica 2019:1-8.
  104. Ezura M, Kikuchi A, Ishiki A, Okamura N, Hasegawa T, Harada R, Watanuki S, Funaki Y, Hiraoka K, Baba T: Longitudinal changes in 18F-THK 5351 positron emission tomography in corticobasal syndrome. European journal of neurology 2019.
  105. Faria DdP, Duran FL, Squarzoni P, Coutinho AM, Garcez AT, Santos PP, Brucki SM, de Oliveira MO, Trés ES, Forlenza OV: Topography of 11C-Pittsburgh compound B uptake in Alzheimer’s disease: a voxel-based investigation of cortical and white matter regions. Brazilian Journal of Psychiatry 2019, 41(2):101-111.
  106. Fassbender TF, Schiller F, Mix M, Maecke HR, Kiefer S, Drendel V, Meyer PT, Jilg CA: Accuracy of [68Ga] Ga-RM2-PET/CT for diagnosis of primary prostate cancer compared to histopathology. Nuclear medicine and biology 2019, 70:32-38.
  107. Fedorova TD, Knudsen K, Hartmann B, Holst JJ, Mortensen FV, Krogh K, Borghammer P: In vivo positron emission tomography imaging of decreased parasympathetic innervation in the gut of vagotomized patients. Neurogastroenterology & Motility 2019:e13759.
  108. Fernandez P, Zanotti-Fregonara P, Eimer S, Gimbert E, Monteil P, Penchet G, Lamare F, Perez P, Vimont D, Ledure S: Combining 3′-Deoxy-3′-[18F] fluorothymidine and MRI increases the sensitivity of glioma volume detection. Nuclear medicine communications 2019, 40(10):1066-1071.
  109. Fiechter M, Bengs S, Roggo A, Haider A, Marędziak M, Portmann A, Treyer V, Burger IA, Messerli M, Patriki D: Association between vertebral bone mineral density, myocardial perfusion, and long-term cardiovascular outcomes: A sex-specific analysis. Journal of Nuclear Cardiology 2019:1-11.
  110. Fiechter M, Haider A, Bengs S, Marędziak M, Burger IA, Roggo A, Portmann A, Schade K, Warnock GI, Treyer V: Sex-dependent association between inflammation, neural stress responses, and impaired myocardial function. European journal of nuclear medicine and molecular imaging 2019:1-6.
  111. Fiechter M, Haider A, Bengs S, Marȩdziak M, Burger IA, Roggo A, Portmann A, Warnock GI, Schade K, Treyer V: Sex Differences in the Association between Inflammation and Ischemic Heart Disease. Thrombosis and haemostasis 2019.
  112. Fiechter M, Roggo A, Burger IA, Bengs S, Treyer V, Becker A, Marȩdziak M, Haider A, Portmann A, Messerli M: Association between resting amygdalar activity and abnormal cardiac function in women and men: a retrospective cohort study. European Heart Journal-Cardiovascular Imaging 2019, 20(6):625-632.
  113. Fiechter M, Roggo A, Haider A, Bengs S, Burger IA, Marędziak M, Portmann A, Treyer V, Becker AS, Messerli M: Metabolic Activity in Central Neural Structures of Patients With Myocardial Injury. Journal of the American Heart Association 2019, 8(19):e013070.
  114. Flanigan M, Tollefson S, Himes ML, Jordan R, Roach K, Stoughton C, Lopresti B, Mason NS, Ciccocioppo R, Narendran R: Acute Elevations in Cortisol Increase the In Vivo Binding of [11C] NOP-1A to Nociceptin Receptors: A Novel Imaging Paradigm to Study the Interaction Between Stress-and Antistress-Regulating Neuropeptides. Biological psychiatry 2019.
  115. Focke C, Blume T, Zott B, Shi Y, Deussing M, Peters F, Schmidt C, Kleinberger G, Lindner S, Gildehaus F-J: Early and Longitudinal Microglial Activation but Not Amyloid Accumulation Predicts Cognitive Outcome in PS2APP Mice. Journal of nuclear medicine 2019, 60(4):548-554.
  116. Forsberg A, Lampa J, Estelius J, Cervenka S, Farde L, Halldin C, Lekander M, Hoglund CO, Kosek E: Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [11C] PBR28 positron emission tomography. Journal of Neuroimmunology 2019:577000.
  117. Fortier M, Castellano C-A, Croteau E, Langlois F, Bocti C, St-Pierre V, Vandenberghe C, Bernier M, Roy M, Descoteaux M: A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment. Alzheimer’s & Dementia 2019, 15(5):625-634.
  118. Freesmeyer M, Winkens T, Kühnel C, Opfermann T, Seifert P: Technetium-99m SPECT/US Hybrid Imaging Compared with Conventional Diagnostic Thyroid Imaging with Scintigraphy and Ultrasound. Ultrasound in medicine & biology 2019, 45(5):1243-1252.
  119. Frisch K, Kjærgaard K, Horsager J, Schacht AC, Munk OL: Human biodistribution, dosimetry, radiosynthesis and quality control of the bile acid PET tracer [N-methyl-11C] cholylsarcosine. Nuclear medicine and biology 2019, 72:55-61.
  120. Fujimoto A, Hori Y, Nagai Y, Kikuchi E, Oyama K, Suhara T, Minamimoto T: Signaling incentive and drive in the primate ventral pallidum for motivational control of goal-directed action. Journal of Neuroscience 2019, 39(10):1793-1804.
  121. Fujiwara K, Tsuji AB, Sudo H, Sugyo A, Akiba H, Iwanari H, Kusano-Arai O, Tsumoto K, Momose T, Hamakubo T: 111 In-labeled anti-cadherin17 antibody D2101 has potential as a noninvasive imaging probe for diagnosing gastric cancer and lymph-node metastasis. Annals of nuclear medicine 2019:1-11.
  122. Fukai M, Bunai T, Hirosawa T, Kikuchi M, Ito S, Minabe Y, Ouchi Y: Endogenous dopamine release under transcranial direct-current stimulation governs enhanced attention: a study with positron emission tomography. Translational psychiatry 2019, 9(1):115.
  123. Gammon ST, Pisaneschi F, Bandi ML, Smith MG, Sun Y, Rao Y, Muller F, Wong F, De Groot J, Ackroyd J: Mechanism-Specific Pharmacodynamics of a Novel Complex-I Inhibitor Quantified by Imaging Reversal of Consumptive Hypoxia with [18F] FAZA PET In Vivo. Cells 2019, 8(12):1487.
  124. Garcia-Arevalo M, Lorza-Gil E, Leite N, Brunetto S, Boschero AC, Carneiro EM: The 17-Beta-Estradiol Improves Insulin Sensitivity in a Rapid Estrogen Receptor Alpha-Dependent Manner in an Animal Model of Malnourishment. Journal of Endocrinology and Metabolism 2019, 9(5):133-146.
  125. Gebhard CE, Marędziak M, Portmann A, Bengs S, Haider A, Fiechter M, Herzog BA, Messerli M, Treyer V, Kudura K: Heart rate reserve is a long-term risk predictor in women undergoing myocardial perfusion imaging. European journal of nuclear medicine and molecular imaging 2019, 46(10):2032-2041.
  126. Geisler S, Stegmayr C, Niemietz N, Lohmann P, Rapp M, Stoffels G, Willuweit A, Galldiks N, Filss CP, Sabel M: Treatment-related uptake of O-(2-[18F] fluoroethyl)-L-tyrosine and L-[methyl-3H]-methionine after tumor resection in rat glioma models. Journal of Nuclear Medicine 2019, 60(10):jnumed. 119.225680.
  127. Gelston D, Alavi A, Rajapakse C: A study on the use of FDG180 via PET-CT for assessing bowel inflammation. Journal of Nuclear Medicine 2019, 60(supplement 1):369-369.
  128. Ghadery C, Koshimori Y, Christopher L, Kim J, Rusjan P, Lang AE, Houle S, Strafella AP: The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson’s Disease. Molecular neurobiology 2019:1-10.
  129. Ghotbi AA, Clemmensen A, Kyhl K, Follin B, Hasbak P, Engstrøm T, Ripa RS, Kjaer A: Rubidium-82 PET imaging is feasible in a rat myocardial infarction model. Journal of Nuclear Cardiology 2019, 26(3):798-809.
  130. Gilbert TM, Zürcher NR, Catanese MC, Tseng C-EJ, Di Biase MA, Lyall AE, Hightower BG, Parmar AJ, Bhanot A, Wu CJ: Neuroepigenetic signatures of age and sex in the living human brain. Nature communications 2019, 10(1):1-9.
  131. Giovannella M, Andresen B, Andersen JB, El-Mahdaoui S, Contini D, Spinelli L, Torricelli A, Greisen G, Durduran T, Weigel UM: Validation of diffuse correlation spectroscopy against 15O-water PET for regional cerebral blood flow measurement in neonatal piglets. Journal of Cerebral Blood Flow & Metabolism 2019:0271678X19883751.
  132. Giridharan VV, Barichello T, Selvaraj S: Molecular Imaging of Blood–Brain Barrier Permeability in Preclinical Models Using PET and SPECT. In: Blood-Brain Barrier. edn.: Springer; 2019: 329-342.
  133. Glud AN, Jakobsen S, Landau AM, Alstrup AKO, Sørensen JCH: Visualization of intrathecal delivery by PET-imaging. Journal of neuroscience methods 2019, 317:45-48.
  134. Golub MS, Hogrefe CE, Campos LJ, Fox AS: Serotonin Transporter Binding Potentials in Brain of Juvenile Monkeys 1 Year After Discontinuation of a 2-Year Treatment With Fluoxetine. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 2019, 4(11):948-955.
  135. González Mancebo D, Becerro AI, Corral A, Moros M, Balcerzyk M, Fuente JsMdl, Ocaña M: Enhancing Luminescence and X-ray Absorption Capacity of Eu3+: LaF3 Nanoparticles by Bi3+ Codoping. ACS Omega 2019, 4(1):765-774.
  136. González Pardo H, Arias Pérez JL, Vallejo Seco G, Conejo Jiménez NM: Influence of environmental enrichment on the volume of brain regions sensitive to early life stress by maternal separation in rats= Influencia del enriquecimiento ambiental en el volumen de regiones cerebrales sensibles a estrés vital temprano por separación materna en ratas. Psicothema 2019.
  137. González-Gómez MA, Belderbos S, Yañez-Vilar S, Piñeiro Y, Cleeren F, Bormans G, Deroose CM, Gsell W, Himmelreich U, Rivas J: Development of Superparamagnetic Nanoparticles Coated with Polyacrylic Acid and Aluminum Hydroxide as an Efficient Contrast Agent for Multimodal Imaging. Nanomaterials 2019, 9(11):1626.
  138. González-Mancebo D, Becerro AI, Corral A, Balcerzyk M, Ocaña M: Luminescence and X-ray Absorption Properties of Uniform Eu3+:(H3O) Lu3F10 Nanoprobes. Nanomaterials 2019, 9(8):1153.
  139. Guberina M, Eberhardt W, Stuschke M, Gauler T, Aigner C, Schuler M, Stamatis G, Theegarten D, Jentzen W, Herrmann K: Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trial. European journal of nuclear medicine and molecular imaging 2019, 46(7):1-9.
  140. Guenthoer P, Fuchs K, Reischl G, Quintanilla-Martinez L, Gonzalez-Menendez I, Laufer S, Pichler BJ, Kneilling M: Evaluation of the therapeutic potential of the selective p38 MAPK inhibitor Skepinone-L and the dual p38/JNK 3 inhibitor LN 950 in experimental K/BxN serum transfer arthritis. Inflammopharmacology 2019, 27(6):1-11.
  141. Haider A, Bengs S, Maredziak M, Messerli M, Fiechter M, Giannopoulos AA, Treyer V, Schwyzer M, Kamani CH, Patriki D: Heart rate reserve during pharmacological stress is a significant negative predictor of impaired coronary flow reserve in women. European journal of nuclear medicine and molecular imaging 2019:1-11.
  142. Haider A, Herder AM, Krämer SD, Varisco J, Keller C, Frauenknecht K, Auberson YP, Temme L, Robaa D, Sippl W: Preclinical Evaluation of Benzazepine-Based PET Radioligands (R)-and (S)-11C-Me-NB1 Reveals Distinct Enantiomeric Binding Patterns and Tightrope Walk between GluN2B-and Sigma1 Receptor-Targeted PET Imaging. Journal of Nuclear Medicine 2019:jnumed. 118.221051.
  143. Haider A, Iten I, Ahmed H, Herde AM, Gruber S, Krämer SD, Keller C, Schibli R, Wünsch B, Mu L: Identification and Preclinical Evaluation of a Radiofluorinated Benzazepine Derivative for Imaging the GluN2B Subunit of the Ionotropic NMDA Receptor. Journal of Nuclear Medicine 2019, 60(2):259-266.
  144. Haider A, Kretz J, Gobbi LC, Ahmed H, Atz K, Bürkler M, Bartelmus C, Fingerle J, Guba W, Ullmer C: Structure-Activity Relationship Studies of Pyridine-Based Ligands and Identification of a Fluorinated Derivative for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors. Journal of medicinal chemistry 2019, 62(24):11165-11181.
  145. Hammoud DA, Sinharay S, Shah S, Schreiber-Stainthorp W, Maric D, Muthusamy S, Lee DE, Lee CA, Basuli F, Reid WC: Neuroinflammatory Changes in Relation to Cerebrospinal Fluid Viral Load in Simian Immunodeficiency Virus Encephalitis. mBio 2019, 10(3):e00970-00919.
  146. Harris DA, Mina A, Cabarkapa D, Heshmati K, Subramaniam R, Banks AS, Tavakkoli A, Sheu EG: Sleeve Gastrectomy enhances glucose utilization and remodels adipose tissue independent of weight loss. bioRxiv 2019:779033.
  147. Hatashita S, Wakebe D: Amyloid β deposition and glucose metabolism on the long-term progression of preclinical Alzheimer’s disease. Future science OA 2019, 5(3):FSO356.
  148. Hatashita S, Wakebe D, Kikuchi Y, Ichijo A: Longitudinal assessment of amyloid-beta deposition by [18F]-flutemetamol PET imaging compared with [11C]-PIB across the spectrum of Alzheimer’s disease. Frontiers in aging neuroscience 2019, 11:251.
  149. Hattori Y, Aoyama K, Maeda J, Arimura N, Takahashi Y, Sasaki M, Fujinaga M, Seki C, Nagai Y, Kawamura K: Design, synthesis, and evaluation of (4R)-1-{3-[2-(18F) fluoro-4-methylpyridin-3-yl] phenyl}-4-[4-(1, 3-thiazol-2-ylcarbonyl) piperazin-1-yl] pyrrolidin-2-one ([18F] T-401) as a novel positron-emission tomography imaging agent for monoacylglycerol lipase. Journal of medicinal chemistry 2019.
  150. Hauser EB, Venturin GT, Greggio S, Borelli WV, DaCosta J: Carotid arterial input function as an inverse problem in kinetic modeling of [18F] 2-fluoro-2 deoxy-D-glucose (FDG). Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization 2019:1-4.
  151. Hauser T-K, Seeger A, Bender B, Klose U, Thurow J, Ernemann U, Tatagiba M, Meyer PT, Khan N, Roder C: Hypercapnic BOLD MRI compared to H215O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease. NeuroImage: Clinical 2019, 22:101713.
  152. Hayer S, Zeilinger M, Weiss V, Dumanic M, Seibt M, Niederreiter B, Shvets T, Pichler F, Wadsak W, Podesser BK: Multimodal [18F] FDG PET/CT is a direct readout for inflammatory bone repair: a longitudinal study in TNFα transgenic mice. Journal of Bone and Mineral Research 2019.
  153. He RY, Lai XM, Sun CS, Kung TS, Hong JY, Jheng YS, Liao WN, Chen JK, Liao YF, Tu PH: Nanoscopic Insights of Amphiphilic Peptide against the Oligomer Assembly Process to Treat Huntington’s Disease. Advanced Science 2019.
  154. He X, Jin C, Ma M, Zhou R, Wu S, Huang H, Li Y, Chen Q, Zhang M, Zhang H: PET imaging on neurofunctional changes after optogenetic stimulation in a rat model of panic disorder. Frontiers of medicine 2019, 13(5):602-609.
  155. Hellwig S, Frings L, Bormann T, Vach W, Buchert R, Meyer PT: Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [18 F] FDG PET. European journal of nuclear medicine and molecular imaging 2019, 46(2):312-323.
  156. Herde AM, Mihov Y, Krämer SD, Mu L, Adamantidis A, Ametamey SM, Hasler G: Chronic Nicotine Exposure Alters Metabotropic Glutamate Receptor 5: Longitudinal PET Study and Behavioural Assessment in Rats. Neurotoxicity research 2019:1-11.
  157. Herde AM, Schibli R, Weber M, Ametamey SM: Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients. European journal of nuclear medicine and molecular imaging 2019, 46(2):407-420.
  158. Hernández Lozano I, Bauer M, Wulkersdorfer B, Traxl A, Philippe C, Weber M, Häusler S, Stieger B, Jäger W, Mairinger S: Measurement of hepatic ABCB1 and ABCG2 transport activity with [11C] tariquidar and PET in humans and mice. Molecular Pharmaceutics 2019.
  159. Hobson BA, Rowland DJ, Sisó S, Guignet MA, Harmany ZT, Bandara S, Saito N, Harvey DJ, Bruun DA, Garbow JR: TSPO PET Using [18F] PBR111 Reveals Persistent Neuroinflammation Following Acute Diisopropylfluorophosphate Intoxication in the Rat. Toxicological Sciences 2019.
  160. Hochstrasser T, Rühling S, Hecher K, Fabisch KH, Chrzanowski U, Brendel M, Eckenweber F, Sacher C, Schmitz C, Kipp M: Stereological Investigation of Regional Brain Volumes after Acute and Chronic Cuprizone-Induced Demyelination. Cells 2019, 8(9):1024.
  161. Hofheinz F, Maus J, Zschaeck S, Rogasch J, Schramm G, Oehme L, Apostolova I, Kotzerke J, van den Hoff J: Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET. EJNMMI research 2019, 9(1):23.
  162. Horakova O, Kroupova P, Bardova K, Buresova J, Janovska P, Kopecky J, Rossmeisl M: Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport. Scientific reports 2019, 9(1):6156.
  163. Hosomi S, Koyama Y, Watabe T, Ohnishi M, Ogura H, Yamashita T, Shimazu T: Myeloid-Derived Suppressor Cells Infiltrate the Brain and Suppress Neuroinflammation in a Mouse Model of Focal Traumatic Brain Injury. Neuroscience 2019, 406:457-466.
  164. Houben RH, Kotsougiani D, Friedrich PF, Shin AY, Bishop AT: Outcomes of Vascularized Bone Allotransplantation with Surgically Induced Autogenous Angiogenesis in a Large Animal Model: Bone Healing, Remodeling, and Material Properties. Journal of reconstructive microsurgery 2019.
  165. Houben RH, Thaler R, Kotsougiani D, Friedrich PF, Shin AY, van Wijnen AJ, Bishop AT: Neo-angiogenesis, transplant viability and molecular analyses of vascularized bone allotransplantation surgery in a large animal model. Journal of Orthopaedic Research® 2019.
  166. Hsieh M-H, Tsai H-W, Lin K-J, Wu Z-Y, Hu H-Y, Chang Y, Wei H-J, Sung H-W: An in situ slow-releasing H2S donor depot with long-term therapeutic effects for treating ischemic diseases. Materials Science and Engineering: C 2019, 104:109954.
  167. Hsu M-N, Huang K-L, Yu F-J, Lai P-L, Truong AV, Lin M-W, Nguyen NTK, Shen C-C, Hwang S-M, Cheng Y-H: Co-Activation of Endogenous Wnt10b and Foxc2 by CRISPR Activation (CRISPRa) Enhances BMSCs Osteogenesis and Promotes Calvarial Bone Regeneration. Molecular Therapy 2019.
  168. Huang C, Wang Z, Liu L, Liu X, Dong J, Xu Q, Zhang B, Miao L: Predicting the dopamine D2 receptor occupancy of ropinirole in rats using positron emission tomography and pharmacokinetic–pharmacodynamic modeling. Xenobiotica 2019, 49(2):143-151.
  169. Huang C-C, Hsiao T, Huang C-Y, Weng Y-C, Huang K-L, Liu C-H, Chang T-Y, Wu H-C, Yen T-C, Lin K-J: Tau PET With 18F-THK-5351 Taiwan Patients With Familial Alzheimer’s Disease With the APP p. D678H Mutation. Frontiers in neurology 2019, 10:503.
  170. Huang C-Y, Hsiao T, Lin K-J, Huang K-L, Fung H-C, Liu C-H, Chang T-Y, Weng Y-C, Hsu W-C, Yen T-C: Amyloid PET pattern with dementia and amyloid angiopathy in Taiwan familial AD with D678H APP mutation. Journal of the neurological sciences 2019, 398:107-116.
  171. Huang EL, Steffen IG, Lukas M, Huang K, Aschenbach JR, Eary JF, Brenner W, Beindorff N: Normal Values for Parotid Gland and Submandibular-Sublingual Salivary Gland Complex Uptake of 99mTechnetium Pertechnetate using SPECT in Mice with Respect to Age, Sex, and Circadian Rhythm. Nuklearmedizin 2019, 58(01):39-49.
  172. Huang K-L, Hsiao T, Kuo H-C, Hsieh C-J, Hsieh Y-C, Wu Y-M, Wey S-P, Yen T-C, Lin K-J, Huang C-C: Correlation between visual association memory test and structural changes in patients with Alzheimer’s disease and amnestic mild cognitive impairment. Journal of the Formosan Medical Association 2019, 118(9):1325-1332.
  173. Huang T, Okauchi T, Hu D, Shigeta M, Wu Y, Wada Y, Hayashinaka E, Wang S, Kogure Y, Noguchi K: Pain matrix shift in the rat brain following persistent colonic inflammation revealed by voxel-based statistical analysis. Molecular pain 2019, 15:1744806919891327.
  174. Huang W-S, Chen G-J, Tsai T-H, Cheng C-Y, Shiue C-Y, Ma K-H, Yeh SH-H: In vivo long-lasting alterations of central serotonin transporter activity and associated dopamine synthesis after acute repeated administration of methamphetamine. EJNMMI research 2019, 9(1):1-10.
  175. Huang Y-Y, Chiu M-J, Yen R-F, Tsai C-L, Hsieh H-Y, Chiu C-H, Wu C-H, Hsin L-W, Tzen K-Y, Cheng C-Y: An one-pot two-step automated synthesis of [18F] T807 injection, its biodistribution in mice and monkeys, and a preliminary study in humans. PloS one 2019, 14(7):e0217384.
  176. Huber M, Beyer L, Prix C, Schönecker S, Palleis C, Rauchmann BS, Morbelli S, Chincarini A, Bruffaerts R, Vandenberghe R: Metabolic correlates of dopaminergic loss in dementia with lewy bodies. Movement disorders 2019.
  177. Huhtala T, Poutiainen P, Rytkönen J, Lehtimäki K, Parkkari T, Kasanen I, Airaksinen AJ, Koivula T, Sweeney P, Kontkanen O: Improved synthesis of [18 F] fallypride and characterization of a Huntington’s disease mouse model, zQ175DN KI, using longitudinal PET imaging of D2/D3 receptors. EJNMMI radiopharmacy and chemistry 2019, 4(1):1-10.
  178. Hulpia F, Verhoeven J, Van Calenbergh S, De Vos F, Kersemans K, Bolcaen J, Goeman J, De Lombaerde S, Descamps B, Hallaert G: New Quick And Easy Publication-Will be edited by Biblio team. Quick And Easy Journal Title 2019.
  179. Ikoma Y, Kimura Y, Yamada M, Obata T, Ito H, Suhara T: Correction of head movement by frame-to-frame image realignment for receptor imaging in positron emission tomography studies with [11 C] raclopride and [11 C] FLB 457. Annals of nuclear medicine 2019, 33(12):916-929.
  180. Inoue Ki, Miyachi S, Nishi K, Okado H, Nagai Y, Minamimoto T, Nambu A, Takada M: Recruitment of calbindin into nigral dopamine neurons protects against MPTP-Induced parkinsonism. Movement Disorders 2019, 34(2):200-209.
  181. Isaac-Olivé K, Ocampo-García BE, Aranda-Lara L, Santos-Cuevas CL, Jiménez-Mancilla NP, Luna-Gutiérrez MA, Medina LA, Nagarajan B, Sabnis N, Raut S: [99m Tc-HYNIC-N-dodecylamide]: a new hydrophobic tracer for labelling reconstituted high-density lipoproteins (rHDL) for radioimaging. Nanoscale 2019, 11(2):541-551.
  182. Ishibashi K, Miura Y, Toyohara J, Ishiwata K, Ishii K: Unchanged type 1 metabotropic glutamate receptor availability in patients with Alzheimer’s disease: A study using 11C-ITMM positron emission tomography. NeuroImage: Clinical 2019:101783.
  183. Jacob A, Ma Y, Nasiri E, Ochani M, Carrion J, Peng S, Brenner M, Huerta PT, Wang P: Extracellular cold inducible RNA-binding protein mediates binge alcohol-induced brain hypoactivity and impaired cognition in mice. Molecular Medicine 2019, 25(1):24.
  184. Jadoul A, Bernard C, Lovinfosse P, Gérard L, Lilet H, Cornet O, Hustinx R: Comparative dosimetry between 99m Tc-MAA SPECT/CT and 90 Y PET/CT in primary and metastatic liver tumors. European journal of nuclear medicine and molecular imaging 2019:1-10.
  185. Jeong J, Jeong YJ, Park KW, Kang D-Y: Cerebral Amyloid Quantification in Cognitively Normal Korean Adults Using F-18 Florbetaben PET. Nuclear medicine and molecular imaging 2019, 53(5):334-339.
  186. Jeong J, Jeong YJ, Park KW, Kang D-Y: Correlation of Early-Phase F-18 Florapronal PET with F-18 FDG PET in Alzheimer’s Disease and Normal Brain. Nuclear medicine and molecular imaging 2019, 53(5):328-333.
  187. Jiao F, Gao Z, Shi K, Jia X, Wu P, Jiang C, Ge J, Su H, Guan Y, Shi S: Frequency-Dependent Relationship Between Resting-State fMRI and Glucose Metabolism in the Elderly. Frontiers in neurology 2019, 10.
  188. Jiao R, Allen KJ, Malo ME, Helal M, Jiang Z, Smart K, Buhl SV, Rickles D, Bryan RA, Dadachova E: Evaluation of novel highly specific antibodies to cancer testis antigen Centrin-1 for radioimmunoimaging and radioimmunotherapy of pancreatic cancer. Cancer medicine 2019, 8(11):5289-5300.
  189. Johnson TB, Brudvig JJ, Lehtimäki KK, Cain JT, White KA, Bragge T, Rytkönen J, Huhtala T, Timm D, Vihma M: A multimodal approach to identify clinically relevant parameters to monitor disease progression in a preclinical model of neuropediatric disease. bioRxiv 2019:522011.
  190. Juarez EJ, Castrellon JJ, Green MA, Crawford JL, Seaman KL, Smith CT, Dang LC, Matuskey D, Morris ED, Cowan RL: Reproducibility of the correlative triad among aging, dopamine receptor availability, and cognition. Psychology and aging 2019, 34(7):921.
  191. Jung KH, Oh SJ, Kang KJ, Han SJ, Nam KR, Park JA, Lee KC, Lee YJ, Choi JY: Effects of P-gp and Bcrp as brain efflux transporters on the uptake of [18F] FPEB in the murine brain. Synapse 2019.
  192. Kaeopookum P, Petrik M, Summer D, Klinger M, Zhai C, Rangger C, Haubner R, Haas H, Hajduch M, Decristoforo C: Comparison of 68Ga-labeled RGD mono-and multimers based on a clickable siderophore-based scaffold. Nuclear medicine and biology 2019, 78:1-10.
  193. Kaeopookum P, Summer D, Pfister J, Orasch T, Lechner BE, Petrik M, Novy Z, Matuszczak B, Rangger C, Haas H: Modifying the Siderophore Triacetylfusarinine C for Molecular Imaging of Fungal Infection. Molecular Imaging and Biology 2019, 21(6):1-10.
  194. Kanda A, Kondo K, Hosaka N, Kobayashi Y, Bui DV, Yun Y, Suzuki K, Sawada S, Asako M, Nakamura A: Eosinophilic Upper Airway Inflammation in a Murine Model Using an Adoptive Transfer System Induces Hyposmia and Epithelial Layer Injury with Convex Lesions. Medical Sciences 2019, 7(2):22.
  195. Kang Y, Henchcliffe C, Verma A, Vallabhajosula S, He B, Kothari PJ, Pryor KO, Mozley PD: 18F-FPEB PET/CT Shows mGluR5 Upregulation in Parkinson’s Disease. Journal of Neuroimaging 2019, 29(1):97-103.
  196. Karkare S, Allen KJ, Jiao R, Malo ME, Dawicki W, Helal M, Godson DL, Dickinson R, MacDonald-Dickinson V, Yang R: Detection and targeting insulin growth factor receptor type 2 (IGF2R) in osteosarcoma PDX in mouse models and in canine osteosarcoma tumors. Scientific reports 2019, 9(1):1-10.
  197. Karlberg A, Berntsen EM, Johansen H, Skjulsvik AJ, Reinertsen I, Dai HY, Xiao Y, Rivaz H, Borghammer P, Solheim O: 18F-FACBC PET/MRI in Diagnostic Assessment and Neurosurgery of Gliomas. Clinical nuclear medicine 2019, 44(7):550-559.
  198. Kawamura K, Yamasaki T, Zhang Y, Wakizaka H, Hatori A, Xie L, Fujinaga M, Zhang M-R: Change in the Binding of [11 C] BU99008 to Imidazoline I 2 Receptor Using Brain PET in Zucker Rats. Molecular Imaging and Biology 2019, 21(1):105-112.
  199. Kazuya M, Ohnishi A, Sasaki M, Ikari Y, Aita K, Watanabe Y, Kusuhara H, Sugiyama Y, Senda M: Quantitative investigation of hepatobiliary transport of [11C] telmisartan in humans by PET imaging. Drug Metabolism and Pharmacokinetics 2019.
  200. Kersemans V, Gilchrist S, Wallington S, Allen PD, Gomes AL, Dias GM, Cornelissen B, Kinchesh P, Smart SC: A Carbon-Fiber Sheet Resistor for MR-, CT-, SPECT-, and PET-Compatible Temperature Maintenance in Small Animals. Tomography 2019, 5(2):274.
  201. Kessler M, Mamach M, Beutelmann R, Lukacevic M, Eilert S, Bascuñana P, Fasel A, Bengel F, Bankstahl J, Ross T: GABA A Receptors in the Mongolian Gerbil: a PET Study Using [18 F] Flumazenil to Determine Receptor Binding in Young and Old Animals. Molecular Imaging and Biology 2019:1-13.
  202. Khor YM, Cuddy S, Harms HJ, Kijewski MF, Park M-A, Robertson M, Hyun H, Di Carli MF, Bianchi G, Landau H: Quantitative [18 F] florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosis. European Journal of Nuclear Medicine and Molecular Imaging 2019:1-12.
  203. Kim D, Yoon H-J, Lee WJ, Woo SH, Kim BS: Prognostic value of 18 F-FDG brain PET as an early indicator of neurological outcomes in a rat model of post-cardiac arrest syndrome. Scientific reports 2019, 9(1):1-9.
  204. Kim HJ, Lim TS, Lee SM, Kim T-S, Kim Y, An Y-S, Youn YC, Park SA, Chang J, Moon SY: Cerebrospinal Fluid Levels of β-Amyloid 40 and β-Amyloid 42 are Proportionately Decreased in Amyloid Positron-Emission Tomography Negative Idiopathic Normal-Pressure Hydrocephalus Patients. Journal of Clinical Neurology 2019, 15(3):353-359.
  205. Kim J, Choi K-H, Cho S-G, Kang S-R, Yoo SW, Kwon SY, Min J-J, Bom H-S, Song H-C: Association of muscle and visceral adipose tissues with the probability of Alzheimer’s disease in healthy subjects. Scientific reports 2019, 9(1):949.
  206. Kim J, Ghadery C, Cho SS, Mihaescu A, Christopher L, Valli M, Houle S, Strafella AP: Network Patterns of Beta-Amyloid Deposition in Parkinson’s Disease. Molecular neurobiology 2019:1-10.
  207. Kim JH, Choe YS, Cumming P, Son YD, Kim HK, Joo YH, Kim JH: Relationship of self-transcendence traits with in vivo dopamine D2/3 receptor availability and functional connectivity: an [18F] fallypride PET and fMRI study. Synapse 2019.
  208. Kim J-H, Joo Y-H, Son Y-D, Kim J-H, Kim Y-K, Kim H-K, Lee S-Y, Ido T: In vivo metabotropic glutamate receptor 5 availability-associated functional connectivity alterations in drug-naïve young adults with major depression. European Neuropsychopharmacology 2019, 29(2):278-290.
  209. Kim MJ, Lee CH, Lee Y, Youn H, Kang KW, Kwon J, Alavi A, Carlin S, Cheon GJ, Chung JK: Glucose-6-phosphatase Expression-Mediated [(18)F]FDG Efflux in Murine Inflammation and Cancer Models. Mol Imaging Biol 2019, 21(5):917-925.
  210. Kim Y-H, Bang J-I, Son H-J, Kim Y, Kim J, Bae H, Han S, Yoon H-J, Kim B: Protective effects of extracorporeal shockwave on rat chondrocytes and temporomandibular joint osteoarthritis; preclinical evaluation with in vivo 99mTc-HDP SPECT and ex vivo micro-CT. Osteoarthritis and cartilage 2019, 27(11):1692-1701.
  211. Kimura H, Yagi Y, Mikamo M, Maeda K, Kagawa S, Arimitsu K, Higashi T, Nishii R, Ono M, Nakamoto Y: Evaluation of transporter-mediated hepatobiliary transport of newly developed 18F-labeled pitavastatin derivative, PTV-F1, in rats by PET imaging. Drug metabolism and pharmacokinetics 2019, 34(5):317-324.
  212. Kircher M, Ihne S, Brumberg J, Morbach C, Knop S, Kortüm KM, Störk S, Buck AK, Reiter T, Bauer WR: Detection of cardiac amyloidosis with 18 F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy. European journal of nuclear medicine and molecular imaging 2019:1-10.
  213. Klinge MW, Borghammer P, Lund S, Fedorova T, Knudsen K, Haase AM, Christiansen JJ, Krogh K: Enteric cholinergic neuropathy in patients with diabetes: Non-invasive assessment with positron emission tomography. Neurogastroenterology & Motility 2019, 32(1):e13731.
  214. Knight JC, Torres JB, Goldin R, Mosley M, Dias GM, Bravo LC, Kersemans V, Allen PD, Mukherjee S, Smart SC: Early Detection in a Mouse Model of Pancreatic Cancer by Imaging DNA Damage Response Signalling. Journal of Nuclear Medicine 2019:jnumed. 119.234708.
  215. Knudsen K, Fedorova TD, Hansen AK, Sommerauer M, Haase A-M, Svendsen KB, Otto M, Østergaard K, Krogh K, Borghammer P: Objective intestinal function in patients with idiopathic REM sleep behavior disorder. Parkinsonism & related disorders 2019, 58:28-34.
  216. Kobayashi R, Hayashi H, Kawakatsu S, Okamura N, Yoshioka M, Otani K: Assessment of amyloid deposition in patients with probable REM sleep behavior disorder as a prodromal symptom of dementia with Lewy bodies using PiB-PET. Frontiers in Neurology 2019, 10:671.
  217. Kolb H, Barret O, Bhattacharya A, Chen G, Constantinescu C, Huang C, Letavic M, Tamagnan G, Xia C, Zhang W: Preclinical evaluation and non-human primate receptor occupancy study of 18F-JNJ-64413739, a novel PET radioligand for P2X7 receptors. Journal of Nuclear Medicine 2019:jnumed. 118.212696.
  218. Kosten L, Deleye S, Stroobants S, Wyffels L, Mingote S, Rayport S, Staelens S: Molecular Imaging of mGluR5 Availability with [11 C] ABP68 in Glutaminase Heterozygous Mice. Cellular and molecular neurobiology 2019, 39(2):255-263.
  219. Kotsougiani D, Hundepool CA, Bulstra LF, Friedrich PF, Shin AY, Bishop AT: Bone vascularized composite allotransplantation model in swine tibial defect: Evaluation of surgical angiogenesis and transplant viability. Microsurgery 2019, 39(2):160-166.
  220. Kramer V, Dyssegaard A, Flores J, Soza-Ried C, Rösch F, Knudsen GM, Amaral H, Herth MM: Characterization of the serotonin 2A receptor selective PET tracer (R)-[18 F] MH. MZ in the human brain. European journal of nuclear medicine and molecular imaging 2019:1-11.
  221. Kramer V, Juri C, Riss PJ, Pruzzo R, Soza-Ried C, Flores J, Hurtado A, Rösch F, Chana-Cuevas P, Amaral H: Pharmacokinetic evaluation of [18 F] PR04. MZ for PET/CT imaging and quantification of dopamine transporters in the human brain. European Journal of Nuclear Medicine and Molecular Imaging 2019:1-11.
  222. Kreimerman I, Reyes L, Paolino A, Pardo T, Porcal W, Oliver P, Savio E, Engler H: Biological assessment of a 18F-labelled Sulforhodamine 101 in a mouse model of Alzheimer’s Disease as a potential astrocytosis marker. Frontiers in neuroscience 2019, 13:734.
  223. Kubik T, Kałużyński K, Burger C, Passeri A, Margiacchi S, Saletti P, Bonini R, Lorenzini E, Sciagrà R: Novel 3D heart left ventricle muscle segmentation method for PET-gated protocol and its verification. Annals of nuclear medicine 2019, 33(8):1-10.
  224. Kuehnel C, Winkens T, Freesmeyer M: Design, construction, and validation of a hybrid phantom for nuclear medicine and ultrasound fusion imaging. Applied Radiation and Isotopes 2019, 145:120-125.
  225. Kühnel C, Seifert P, Mulik C, Winkens T, Freesmeyer M: 3D printing of fillable individual thyroid replicas based on nuclear medicine DICOM data used as phantoms for gamma probe calibration. Nuklearmedizin 2019.
  226. Kushchayeva YS, Startzell M, Cochran E, Auh S, Sekizkardes H, Soldin SJ, Kushchayev SV, Dieckmann W, Skarulis M, Abdul Sater Z: Thyroid hormone effects on glucose disposal in patients with insulin receptor mutations. The Journal of Clinical Endocrinology & Metabolism 2019.
  227. Kuttner S, Wickstrøm KK, Kalda G, Dorraji SE, Martin-Armas M, Oteiza A, Jenssen R, Fenton K, Sundset R, Axelsson J: Machine learning derived input-function in a dynamic 18 F-FDG PET study of mice. Biomedical Physics & Engineering Express 2019.
  228. Laguna M, Nuñez NO, Becerro AI, Lozano G, Moros M, Jesús M, Corral A, Balcerzyk M, Ocaña M: Synthesis, functionalization and properties of uniform europium-doped sodium lanthanum tungstate and molybdate (NaLa (XO4) 2, X= Mo, W) probes for luminescent and X-ray computed tomography bioimaging. Journal of colloid and interface science 2019, 554:520-530.
  229. Lahiri S, Kim H, Garcia-Perez I, Reza MM, Martin KA, Kundu P, Cox LM, Selkrig J, Posma JM, Zhang H: The gut microbiota influences skeletal muscle mass and function in mice. Science translational medicine 2019, 11(502):eaan5662.
  230. Lan Y, Bai P, Chen Z, Neelamegam R, Placzek MS, Wang H, Fiedler SA, Yang J, Yuan G, Qu X: Novel radioligands for imaging sigma-1 receptor in brain using positron emission tomography (PET). Acta Pharmaceutica Sinica B 2019, 9(6):1204-1215.
  231. Lane N, Nyman J, Uppuganti S, Chaudhari A, Aguirre J, Shidara K, Liu X, Yao W, Kimmel D: Inhibition of vascular endothelial growth factor in young adult mice causes low bone blood flow and bone strength with no effect on bone mass in trabecular regions. Bone Reports 2019:100210.
  232. Lavisse S, Williams S, Lecourtois S, van Camp N, Guillermier M, Gipchtein P, Jan C, Goutal S, Eymin L, Valette J: Longitudinal characterization of cognitive and motor deficits in an excitotoxic lesion model of striatal dysfunction in non-human primates. Neurobiology of disease 2019, 130:104484.
  233. Ledermann K, Hasler G, Jenewein J, Sprott H, Schnyder U, Martin-Soelch C: 5’UTR polymorphism in the serotonergic receptor HTR3A gene is differently associated with striatal Dopamine D2/D3 receptor availability in the right putamen in Fibromyalgia patients and healthy controls–preliminary evidence. Synapse 2019.
  234. Lee HS, Kang Y-k, Lee H, Han JH, Moon BS, Byun S-S, Chae D-W, Kang KW, Lee WW: Compartmental-modelling-based measurement of murine glomerular filtration rate using 18 F-fluoride PET/CT. Scientific reports 2019, 9(1):1-9.
  235. Lee JW, Song YS, Kim H, Ku BD, Lee WW: Alteration of tremor dominant and postural instability gait difficulty subtypes during the progression of Parkinson’s disease: analysis of the PPMI cohort. Frontiers in neurology 2019, 10:471.
  236. Lee M, Lee H-J, Jeong YJ, Oh SJ, Kang KJ, Han SJ, Nam KR, Lee YJ, Lee KC, Ryu YH: Age dependency of mGluR5 availability in 5xFAD mice measured by PET. Neurobiology of Aging 2019, 84:208-216.
  237. Lee MJ, Pak K, Kim JH, Kim YJ, Yoon J, Lee J, Lyoo CH, Park HJ, Lee J-H, Jung N-Y: Effect of polygenic load on striatal dopaminergic deterioration in Parkinson disease. Neurology 2019, 93(7):e665-e674.
  238. Legrand M, Galineau L, Novell A, Planchez B, Brizard B, Leman S, Tauber C, Escoffre J-M, Lefèvre A, Gosset P: Efficacy of chronic ultrasound neurostimulation on behaviors and distributed brain metabolism in depressive-like mice. BioRxiv 2019:813006.
  239. Lehner E, Gündel D, Liebau A, Plontke S, Mäder K: Intracochlear PLGA based implants for dexamethasone release: challenges and solutions. International Journal of Pharmaceutics: X 2019, 1:100015.
  240. Leiter I, Bascuñana P, Bengel FM, Bankstahl JP, Bankstahl M: Attenuation of epileptogenesis by 2-deoxy-d-glucose is accompanied by increased cerebral glucose supply, microglial activation and reduced astrocytosis. Neurobiology of disease 2019:104510.
  241. Leonel ECR, Corral A, Risco R, Camboni A, Taboga SR, Kilbride P, Vazquez M, Morris J, Dolmans M-M, Amorim CA: Stepped vitrification technique for human ovarian tissue cryopreservation. Scientific Reports 2019, 9(1):1-12.
  242. Lesniak WG, Chu C, Jablonska A, Azad BB, Zwaenepoel O, Zawadzki M, Lisok A, Pomper MG, Walczak P, Gettemans J: PET imaging of distinct brain uptake of a nanobody and similarly-sized PAMAM dendrimers after intra-arterial administration. European journal of nuclear medicine and molecular imaging 2019, 46(9):1-12.
  243. Lesniak WG, Chu C, Jablonska A, Du Y, Pomper MG, Walczak P, Janowski M: A distinct advantage to intraarterial delivery of 89Zr-bevacizumab in PET imaging of mice with and without osmotic opening of the blood–brain barrier. Journal of Nuclear Medicine 2019, 60(5):617-622.
  244. L’Estrade ET, Shalgunov V, Edgar FG, Strebl-Bantillo MG, Xiong M, Crestey F, Neelamegam R, Dyssegaard A, Lehel S, Erlandsson M: Radiosynthesis and preclinical evaluation of [11C] Cimbi-701–Towards the imaging of cerebral 5-HT7 receptors. Journal of Labelled Compounds and Radiopharmaceuticals 2019.
  245. Leuzy A, Cicognola C, Chiotis K, Saint-Aubert L, Lemoine L, Andreasen N, Zetterberg H, Ye K, Blennow K, Höglund K: Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease. European journal of nuclear medicine and molecular imaging 2019:1-12.
  246. LEVY CdS, COSTA FGdB, FARIA DdP, STEFANO JT, COGLIATI B, OLIVEIRA CP: 18F-FDG PET/CT as an assessment tool of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease development in experimental model. Arquivos de gastroenterologia 2019(AHEAD).
  247. Li D, Zou S, Cheng S, Song S, Wang P, Zhu X: Monitoring the response of PD-L1 expression to EGFR-TKIs in NSCLC xenografts by immuno-PET imaging. Molecular Pharmaceutics 2019.
  248. Li R, Li K, Zhang L, Wang L, Chen N, Deng X, Luo M, Wu J: Autologous transplantation of photoactivated subcutaneous adipose tissue improves glucose homeostasis in high-fat diet-induced obese mice. Journal of Tissue Engineering and Regenerative Medicine 2019, 13(9):1609-1617.
  249. Lin PY, Chen KH, Miao YB, Chen HL, Lin KJ, Chen CT, Yeh CN, Chang Y, Sung HW: Phase-Changeable Nanoemulsions for Oral Delivery of a Therapeutic Peptide: Toward Targeting the Pancreas for Antidiabetic Treatments Using Lymphatic Transport. Advanced Functional Materials 2019:1809015.
  250. Lindberg A, Lu S, Nag S, Schou M, Liow J-S, Zoghbi SS, Frankland MP, Gladding RL, Morse CL, Takano A: Synthesis and evaluation of two new candidate high-affinity full agonist PET radioligands for imaging 5-HT1B receptors. Nuclear medicine and biology 2019, 70:1-13.
  251. Liu X, Ye J, Zhang Y, Liu Q, Bai R, Yuan W, Cai D, Zheng X, Bian Y, Zhou S: Ocular Biodistribution of 89 Zr-Bevacizumab in New Zealand Rabbits Determined Using PET/MRI: A Feasibility Study. Iranian Journal of Radiology 2019, 16(2).
  252. Lobaz V, Konefał R, Pánek J, Vlk M, Kozempel J, Petřík M, Novy Z, Gurská S, Znojek P, Štěpánek P: In Situ In Vivo radiolabeling of polymer-coated hydroxyapatite nanoparticles to track their biodistribution in mice. Colloids and Surfaces B: Biointerfaces 2019.
  253. Lohith TG, Bennacef I, Vandenberghe R, Vandenbulcke M, Salinas CA, Declercq R, Reynders T, Telan-Choing NF, Riffel K, Celen S: Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with 18F-MK-6240, a PET Tracer Targeting Neurofibrillary Tangles. Journal of Nuclear Medicine 2019, 60(1):107-114.
  254. Lohmann P, Stavrinou P, Lipke K, Bauer EK, Ceccon G, Werner J-M, Neumaier B, Fink GR, Shah NJ, Langen K-J: FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma. European journal of nuclear medicine and molecular imaging 2019, 46(3):591-602.
  255. López-González FJ, Paredes-Pacheco J, Thurnhofer-Hemsi K, Rossi C, Enciso M, Toro-Flores D, Murcia-Casas B, Gutiérrez-Cardo AL, Roé-Vellvé N: QModeling: a Multiplatform, Easy-to-Use and Open-Source Toolbox for PET Kinetic Analysis. Neuroinformatics 2019, 17(1):103-114.
  256. Lopez-Pastor AR, Gomez-Hernandez A, Diaz-Castroverde S, Gonzalez-Aseguinolaza G, Gonzalez-Rodriguez A, Garcia G, Fernandez S, Escribano O, Benito M: Liver-specific insulin receptor isoform A expression enhances hepatic glucose uptake and ameliorates liver steatosis in a mouse model of diet-induced obesity. Disease models & mechanisms 2019, 12(2):dmm036186.
  257. Lozano IH, Karch R, Bauer M, Blaickner M, Matsuda A, Wulkersdorfer B, Hacker M, Zeitlinger M, Langer O: Towards Improved Pharmacokinetic Models for the Analysis of Transporter-Mediated Hepatic Disposition of Drug Molecules with Positron Emission Tomography. The AAPS journal 2019, 21(4):61.
  258. Luft C, Greggio S, Venturin GT, da Costa MS, da Costa JC, Donadio MVF: Sex differences in the effects of acute stress on cerebral glucose metabolism: A microPET study. Brain research 2019, 1722:146355.
  259. Macaisa CM, Watabe T, Liu Y, Romanov V, Kanai Y, Horitsugi G, Kato H, Shimosegawa E, Hatazawa J: Preserved Cerebral Oxygen Metabolism in Astrocytic Dysfunction: A Combination Study of 15O-Gas PET with 14C-Acetate Autoradiography. Brain sciences 2019, 9(5):101.
  260. MacAskill MG, Walton T, Williams L, Morgan TE, Alcaide-Corral CJ, Dweck MR, Gray GA, Newby DE, Lucatelli C, Sutherland A: Kinetic modelling and quantification bias in small animal PET studies with [18F] AB5186, a novel 18 kDa translocator protein radiotracer. PloS one 2019, 14(5):e0217515.
  261. Maier FC, Schweifer A, Damaraju VL, Cass CE, Bowden GD, Ehrlichmann W, Kneilling M, Pichler BJ, Hammerschmidt F, Reischl G: 2-Nitroimidazole-Furanoside Derivatives for Hypoxia Imaging—Investigation of Nucleoside Transporter Interaction, 18F-Labeling and Preclinical PET Imaging. Pharmaceuticals 2019, 12(1):31.
  262. Malbert CH, Genissel M, Divoux JL, Henry C: Chronic abdominal vagus stimulation increased brain metabolic connectivity, reduced striatal dopamine transporter and increased mid-brain serotonin transporter in obese miniature pigs. J Transl Med 2019, 17(1):78.
  263. Maleki-Balajoo S, Rahmani F, Khosrowabadi R, Meng C, Grimmer T, Drzezga A, Zarei M, Sorg C, Tahmasian M: Decoupling of inter-regional functional connectivity and regional neural activity in Alzheimer Disease. bioRxiv 2019:642629.
  264. Mannheim JG, Mamach M, Reder S, Traxl A, Mucha N, Disselhorst JA, Mittelhäuser M, Kuntner C, Thackeray JT, Ziegler S: Reproducibility and comparability of preclinical PET imaging data: A multi-center small animal PET study. Journal of Nuclear Medicine 2019:jnumed. 118.221994.
  265. Manos-Turvey A, Becker G, Francotte P, Serrano ME, Luxen A, Pirotte B, Plenevaux A, Lemaire C: Fully automated synthesis and evaluation of [18F] BPAM121: Potential of an AMPA receptor positive allosteric modulator as PET radiotracer. ChemMedChem 2019, 14(7):788-795.
  266. Manzano-Crespo M, Atienza M, Cantero JL: Lower serum expression of miR-181c-5p is associated with increased plasma levels of amyloid-beta 1–40 and cerebral vulnerability in normal aging. Translational neurodegeneration 2019, 8(1):34.
  267. Maschauer S, Ott JJ, Bernhardt G, Kuwert T, Keller M, Prante O: 18 F-labelled triazolyl-linked argininamides targeting the neuropeptide YY 1 R for PET imaging of mammary carcinoma. Scientific reports 2019, 9(1):1-12.
  268. McDonald ES, Doot RK, Young AJ, Schubert EK, Pryma DA, Farwell MD, Tchou J, Nayak A, Ziober A, Feldman MD: Breast Cancer 18F-ISO-1 Uptake as a Marker of Proliferation Status. Journal of Nuclear Medicine 2019:jnumed. 119.232363.
  269. Michelson D, Grundman M, Magnuson K, Fisher R, Levenson J, Aisen P, Marek K, Gray M, Hefti F: Randomized, Placebo Controlled Trial of NPT088, A Phage-Derived, Amyloid-Targeted Treatment for Alzheimer’s Disease. The journal of prevention of Alzheimer’s disease 2019, 6(4):228-231.
  270. Miller IS, Shiels LP, Conroy E, Connor K, Dicker P, Gallagher WM, O’Donovan N, Kerbel RS, Crown J, Byrne AT: Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents. Scientific Reports 2019, 9(1):9204.
  271. Min B-K, Oh CJ, Park S, Lee J-M, Go Y, Park B-Y, Kang H-J, Kim DW, Kim J-E, Yoo EK: Therapeutic effect of dichloroacetate against atherosclerosis via hepatic FGF21 induction mediated by acute AMPK activation. Experimental & Molecular Medicine 2019, 51(10):1-12.
  272. Minn I, Huss DJ, Ahn H-H, Chinn TM, Park A, Jones J, Brummet M, Rowe SP, Sysa-Shah P, Du Y: Imaging CAR T cell therapy with PSMA-targeted positron emission tomography. Science advances 2019, 5(7):eaaw5096.
  273. Miranda A, Glorie D, Bertoglio D, Vleugels J, De Bruyne G, Stroobants S, Staelens S, Verhaeghe J: Awake 18F-FDG PET Imaging of Memantine-Induced Brain Activation and Test–Retest in Freely Running Mice. Journal of Nuclear Medicine 2019, 60(6):844-850.
  274. Miranda A, Kang MS, Blinder S, Bouhachi R, Soucy JP, Aliaga-Aliaga A, Massarweh G, Stroobants S, Staelens S, Rosa-Neto P et al: PET imaging of freely moving interacting rats. Neuroimage 2019, 191:560-567.
  275. Missault S, Anckaerts C, Blockx I, Deleye S, Van Dam D, Barriche N, De Pauw G, Aertgeerts S, Valkenburg F, De Deyn PP: Neuroimaging of subacute brain inflammation and microstructural changes predicts long-term functional outcome after experimental traumatic brain injury. Journal of neurotrauma 2019, 36(5):768-788.
  276. Mitran B, Andersson KG, Lindström E, Garousi J, Rosestedt M, Tolmachev V, Ståhl S, Orlova A, Löfblom J: Affibody‑mediated imaging of EGFR expression in prostate cancer using radiocobalt‑labeled DOTA‑ZEGFR: 2377. Oncology reports 2019, 41(1):534-542.
  277. Miyamoto M, Miyamoto T, Saitou J, Sato T: Longitudinal study of striatal aromatic l-amino acid decarboxylase activity in patients with idiopathic rapid eye movement sleep behavior disorder. Sleep Medicine 2019.
  278. Møller A, Rømer Thomsen K, Brooks DJ, Mouridsen K, Blicher JU, Hansen KV, Lou HC: Attenuation of dopamine-induced GABA release in problem gamblers. Brain and behavior 2019:e01239.
  279. Mueller A, Bullich S, Barret O, Madonia J, Berndt M, Papin C, Perrotin A, Koglin N, Kroth H, Pfeifer A: Tau PET imaging with 18F-PI-2620 in patients with Alzheimer’s disease and healthy controls: a first-in-human study. Journal of Nuclear Medicine 2019:jnumed. 119.236224.
  280. Mukai H, Hatanaka K, Yagi N, Warashina S, Zouda M, Takahashi M, Narushima K, Yabuuchi H, Iwano J, Kuboyama T: Pharmacokinetic evaluation of liposomal nanoparticle-encapsulated nucleic acid drug: A combined study of dynamic PET imaging and LC/MS/MS analysis. Journal of controlled release 2019, 294:185-194.
  281. Müller-Vahl K, Szejko N, Wilke F, Jakubovski E, Geworski L, Bengel F, Berding G: Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder. Scientific reports 2019, 9(1):972.
  282. Nack A, Brendel M, Nedelcu J, Daerr M, Nyamoya S, Beyer C, Focke C, Deussing M, Hoornaert C, Ponsaerts P: Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models. Cells 2019, 8(2):94.
  283. Nagai Y, Miyakawa N, Takuwa H, Hori Y, Oyama K, Ji B, Takahashi M, Huang X-P, Slocum S, DiBerto JF: Deschloroclozapine: a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys. bioRxiv 2019:854513.
  284. Nakamura T, Hiraoka K, Harada R, Matsuzawa T, Ishikawa Y, Funaki Y, Yoshikawa T, Tashiro M, Yanai K, Okamura N: Brain histamine H1 receptor occupancy after oral administration of desloratadine and loratadine. Pharmacology research & perspectives 2019, 7(4):e00499.
  285. Narendran R, Tollefson S, Fasenmyer K, Paris J, Himes ML, Lopresti B, Ciccocioppo R, Mason NS: Decreased nociceptin receptors are related to resilience and recovery in college women who have experienced sexual violence: therapeutic implications for posttraumatic stress disorder. Biological psychiatry 2019.
  286. Navalpotro-Gomez I, Dacosta-Aguayo R, Molinet-Dronda F, Martin-Bastida A, Botas-Peñin A, Jimenez-Urbieta H, Delgado-Alvarado M, Gago B, Quiroga-Varela A, Rodriguez-Oroz MC: Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson’s disease patients with impulse control disorders. European journal of nuclear medicine and molecular imaging 2019, 46(10):2065-2076.
  287. Nazir MS, Gould S-M, Milidonis X, Reyes E, Ismail TF, Neji R, Roujol S, O’Doherty J, Xue H, Barrington SF: Simultaneous 13 N-Ammonia and gadolinium first-pass myocardial perfusion with quantitative hybrid PET-MR imaging: a phantom and clinical feasibility study. European journal of hybrid imaging 2019, 3(1):1-14.
  288. Neth BJ, Mintz A, Whitlow C, Jung Y, Sai KS, Register TC, Kellar D, Lockhart SN, Hoscheidt S, Maldjian J: Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer’s disease: a pilot study. Neurobiology of aging 2019.
  289. Neves LT, Neves PFR, Paz LV, Zancan M, Milanesi BB, Lazzari GZ, da Silva RB, de Oliveira MMBP, Venturin GT, Greggio S: Increases in dendritic spine density in BLA without metabolic changes in a rodent model of PTSD. Brain Structure and Function 2019, 224(8):2857-2870.
  290. Nicolas CT, Hickey RD, Allen KL, Du Z, VanLith CJ, Guthman RM, Amiot B, Suksanpaisan L, Han B, Francipane MG: Ectopic hepatocyte transplantation cures the pig model of tyrosinemia. bioRxiv 2019:648493.
  291. Nikolaus S, Wittsack H-J, Beu M, Antke C, Hautzel H, Wickrath F, Müller-Lutz A, Silva MADS, Huston JP, Antoch G: Amantadine enhances nigrostriatal and mesolimbic dopamine function in the rat brain in relation to motor and exploratory activity. Pharmacology Biochemistry and Behavior 2019, 179:156-170.
  292. Nikolaus S, Wittsack H-J, Wickrath F, Müller-Lutz A, Hautzel H, Beu M, Antke C, Mamlins E, Silva MADS, Huston JP: Differential effects of D-cycloserine and amantadine on motor behavior and D 2/3 receptor binding in the nigrostriatal and mesolimbic system of the adult rat. Scientific reports 2019, 9(1):1-14.
  293. No H-J, Yi H-A, Won KS, Chang HW, Kim HW: Association between white matter lesions and cerebral glucose metabolism in patients with cognitive impairment. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2019.
  294. No H-J, Yi H-A, Won KS, Chang HW, Kim HW: Asociación entre daños en la sustancia blanca y metabolismo de la glucosa cerebral en pacientes con disfunción cognitiva. Revista Española de Medicina Nuclear e Imagen Molecular 2019, 38(3):160-166.
  295. Normand G, Lemoine S, Le Bars D, Merida I, Irace Z, Troalen T, Costes N, Juillard L: PET [11C] acetate is also a perfusion tracer for kidney evaluation purposes. Nuclear medicine and biology 2019, 76:10-14.
  296. Novy Z, Stepankova J, Hola M, Flasarova D, Popper M, Petrik M: Preclinical Evaluation of Radiolabeled Peptides for PET Imaging of Glioblastoma Multiforme. Molecules 2019, 24(13):2496.
  297. Okonkwo DO, Puffer RC, Minhas DS, Beers SR, Edelman KL, Sharpless JM, Laymon CM, Lopresti BJ, Benso S, Puccio AM: [18F] FDG,[11C] PiB, and [18F] AV-1451 PET imaging of neurodegeneration in two subjects with a history of repetitive trauma and cognitive decline. Frontiers in neurology 2019, 10:831.
  298. O’Neill E, Kersemans V, Allen PD, Terry SY, Torres JB, Mosley M, Smart SC, Lee BQ, Falzone N, Vallis KA: Imaging DNA Damage Repair in vivo Following 177Lu-DOTATATE Therapy. Journal of Nuclear Medicine 2019:jnumed. 119.232934.
  299. Ooms M, Tsujikawa T, Lohith TG, Mabins SN, Zoghbi SS, Sumitomo A, Jaaro-Peled H, Kimura Y, Telu S, Pike VW: [11C](R)-Rolipram positron emission tomography detects DISC1 inhibition of phosphodiesterase type 4 in live Disc1 locus-impaired mice. Journal of Cerebral Blood Flow & Metabolism 2019, 39(7):1306-1313.
  300. Orteca G, Pisaneschi F, Rubagotti S, Liu TW, Biagiotti G, Piwnica-Worms D, Iori M, Capponi PC, Ferrari E, Asti M: Development of a Potential Gallium-68-Labelled Radiotracer Based on DOTA-Curcumin for Colon-Rectal Carcinoma: From Synthesis to In Vivo Studies. Molecules 2019, 24(3):644.
  301. Otaki Y, Manabe O, Miller RJ, Manrique A, Nganoa C, Roth N, Berman DS, Germano G, Slomka PJ, Agostini D: Quantification of myocardial blood flow by CZT-SPECT with motion correction and comparison with 15 O-water PET. Journal of Nuclear Cardiology 2019:1-10.
  302. Ottoy J, Niemantsverdriet E, Verhaeghe J, De Roeck E, Struyfs H, Somers C, Ceyssens S, Van Mossevelde S, Van den Bossche T, Van Broeckhoven C: Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid-and 18F-FDG-PET imaging. NeuroImage: Clinical 2019, 22:101771.
  303. Ottoy J, Verhaeghe J, Niemantsverdriet E, De Roeck E, Ceyssens S, Van Broeckhoven C, Engelborghs S, Stroobants S, Staelens S: 18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer’s disease: Validation against 15O-H2O PET. Alzheimer’s & Dementia 2019, 15(9):1172-1182.
  304. Ouach A, Vercouillie J, Bertrand E, Rodrigues N, Pin F, Serriere S, Boiaryna L, Chartier A, Percina N, Tangpong P: Bis (het) aryl-1, 2, 3-triazole quinuclidines as α7 nicotinic acetylcholine receptor ligands: Synthesis, structure affinity relationships, agonism activity,[18F]-radiolabeling and PET study in rats. European Journal of Medicinal Chemistry 2019.
  305. Overgaard MD, Duvald CS, Vendelbo MH, Pedersen SB, Jakobsen S, Alstrup AKO, Mikkelsen E, Ovesen PG, Pedersen M: Biodistribution of [11C]-Metformin and mRNA Expression of Placentae Metformin Transporters in the Pregnant Chinchilla. Contrast Media & Molecular Imaging 2019, 2019:9787340.
  306. Owen J, Thomas E, Menon J, Gray M, Skaripa-Koukelli I, Gill MR, Wallington S, Miller RL, Vallis K, Carlisle R: Indium-111 labelling of liposomal HEGF for radionuclide delivery via ultrasound-induced cavitation. Journal of Controlled Release 2019.
  307. Pak K, Kim H, Seok JW, Lee MJ, Shin S, Kim K, Lee JM, Seo Y, Kim BS, Jun S: Prediction of future weight change with dopamine transporter in patients with Parkinson’s disease. Journal of Neural Transmission 2019:1-7.
  308. Pak K, Kim K, Lee MJ, Lee JM, Kim BS, Kim S-J, Kim IJ: Prediction of future weight change with the dopamine transporter. Brain imaging and behavior 2019, 13(3):588-593.
  309. Palard-Novello X, Beuzit L, Gambarota G, Le Jeune F, Garin E, Salaün P-Y, Devillers A, Querellou S, Bourguet P, Saint-Jalmes H: Comparison of 18 F-Choline PET/CT and MRI functional parameters in prostate cancer. Annals of nuclear medicine 2019, 33(1):47-54.
  310. Pang H-H, Chen P-Y, Wei K-C, Huang C-W, Shiue Y-L, Huang C-Y, Yang H-W: Convection-Enhanced Delivery of a Virus-Like Nanotherapeutic Agent with Dual-Modal Imaging for Besiegement and Eradication of Brain Tumors. Theranostics 2019, 9(6):1752.
  311. Pannell M, Economopoulos V, Wilson TC, Kersemans V, Isenegger PG, Larkin JR, Smart S, Gilchrist S, Gouverneur V, Sibson NR: Imaging of translocator protein upregulation is selective for pro-inflammatory polarized astrocytes and microglia. Glia 2019.
  312. Paranjpe MD, Chen X, Liu M, Paranjpe I, Leal JP, Wang R, Pomper MG, Wong DF, Benzinger TL, Zhou Y: The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study. NeuroImage: Clinical 2019, 22.
  313. Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, Nuscher B, Xiong M, Ghasemigharagoz A, Katzmarski N: Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nature neuroscience 2019, 22(2):191.
  314. Park H, Kim HS, Hong YJ, Min J-J, Kim HB, Kim MC, Sim DS, Kim JH, Kim D-Y, Lee JS: Therapeutic Effect of Fimasartan in a Rat Model of Myocardial Infarction Evaluated by Cardiac Positron Emission Tomography with [18F] FPTP. Chonnam Medical Journal 2019, 55(2):109-115.
  315. Park J, Kim S-E, Kim E-J, Lee BI, Jeong JH, Na HR, Choi SH, Kang D-Y, Park KW: Effect of 12-week home-based cognitive training on cognitive function and brain metabolism in patients with amnestic mild cognitive impairment. Clinical interventions in aging 2019, 14:1167.
  316. Park J-H, Hong J-H, Lee S-W, Ji HD, Jung J-A, Yoon K-W, Lee J-I, Won KS, Song B-I, Kim HW: The effect of chronic cerebral hypoperfusion on the pathology of Alzheimer’s disease: A positron emission tomography study in rats. Scientific reports 2019, 9(1):1-9.
  317. Park SH, Song YS, Moon BS, Lee BC, Park HS, Kim SE: Combination of In Vivo [123I] FP-CIT SPECT and Microdialysis Reveals an Antipsychotic Drug Haloperidol-induced Synaptic Dopamine Availability in the Rat Midbrain and Striatum. Experimental neurobiology 2019, 28(5):602.
  318. Pascual B, Funk Q, Zanotti-Fregonara P, Pal N, Rockers E, Yu MM, Spann B, Román GC, Schulz PE, Karmonic C: Multimodal 18F-AV-1451 and MRI findings in non-fluent variant primary progressive aphasia: possible insights on nodal propagation of tau protein across the syntactic network. Journal of Nuclear Medicine 2019:jnumed. 118.225508.
  319. Paul S, Gallagher E, Liow J-S, Mabins S, Henry K, Zoghbi SS, Gunn RN, Kreisl WC, Richards EM, Zanotti-Fregonara P: Building a database for brain 18 kDa translocator protein imaged using [11C] PBR28 in healthy subjects. Journal of Cerebral Blood Flow & Metabolism 2019, 39(6):1138-1147.
  320. Paul S, Haskali MB, Liow J-S, Zoghbi SS, Barth VN, Kolodrubetz MC, Bond MR, Morse CL, Gladding RL, Frankland MP: Evaluation of a PET Radioligand to Image O-GlcNAcase in Brain and Periphery of Rhesus Monkey and Knock-Out Mouse. Journal of Nuclear Medicine 2019, 60(1):129-134.
  321. Pauwelyn G, Vlerick L, Dockx R, Verhoeven J, Dobbeleir A, Peremans K, Goethals I, Bosmans T, Vanhove C, De Vos F: PET quantification of [18F] MPPF in the canine brain using blood input and reference tissue modelling. PloS one 2019, 14(6):e0218237.
  322. Peng S-L, Chiu H, Wu C-Y, Huang C-W, Chung Y-H, Shih C-T, Shen W-C: The effect of caffeine on cerebral metabolism during alpha-chloralose anesthesia differs from isoflurane anesthesia in the rat brain. Psychopharmacology 2019, 236(6):1-9.
  323. Pereira HR, Ferreira HA: Classification of Patients with Parkinson’s Disease Using Medical Imaging and Artificial Intelligence Algorithms. In: Mediterranean Conference on Medical and Biological Engineering and Computing: 2019: Springer; 2019: 2043-2056.
  324. Peretti DE, García DV, Reesink FE, Doorduin J, de Jong BM, De Deyn PP, Dierckx RA, Boellaard R: Diagnostic performance of regional cerebral blood flow images derived from dynamic PIB scans in Alzheimer’s disease. EJNMMI research 2019, 9(1):1-9.
  325. Peretti DE, García DV, Reesink FE, van der Goot T, De Deyn PP, de Jong BM, Dierckx RA, Boellaard R: Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer’s disease PET studies. PloS one 2019, 14(1):e0211000.
  326. Philippe C, Zeilinger M, Dumanic M, Pichler F, Fetty L, Vraka C, Balber T, Wadsak W, Pallitsch K, Spreitzer H: SNAPshots of the MCHR1: a Comparison Between the PET-Tracers [18 F] FE@ SNAP and [11 C] SNAP-7941. Molecular Imaging and Biology 2019, 21(2):257-268.
  327. Ponto LLB, Moser DJ, Menda Y, Harlynn EL, DeVries SD, Oleson JJ, Magnotta VA, Schultz SK: Early Phase PIB-PET as a Surrogate for Global and Regional Cerebral Blood Flow Measures. J Neuroimaging 2019, 29(1):85-96.
  328. Prando S, Carneiro CdG, Otsuki DA, Sapienza MT: Effects of ketamine/xylazine and isoflurane on rat brain glucose metabolism measured by 18F-fluorodeoxyglucose-positron emission tomography. European Journal of Neuroscience 2019, 49(1):51-61.
  329. Prando S, Carneiro CdG, Robilotta CC, Sapienza MT: Comparison of different quantification methods for 18F-fluorodeoxyglucose-positron emission tomography studies in rat brains. Clinics 2019, 74:e1273.
  330. Puig O, Henriksen OM, Vestergaard MB, Hansen AE, Andersen FL, Ladefoged CN, Rostrup E, Larsson HB, Lindberg U, Law I: Comparison of simultaneous arterial spin labeling MRI and 15O-H2O PET measurements of regional cerebral blood flow in rest and altered perfusion states. Journal of Cerebral Blood Flow & Metabolism 2019:0271678X19874643.
  331. Puig O, Vestergaard MB, Lindberg U, Hansen AE, Ulrich A, Andersen FL, Johannesen HH, Rostrup E, Law I, Larsson HB: Phase contrast mapping MRI measurements of global cerebral blood flow across different perfusion states–A direct comparison with 15O-H2O positron emission tomography using a hybrid PET/MR system. Journal of Cerebral Blood Flow & Metabolism 2019, 39(12):2368-2378.
  332. Pulagam KR, Gona KB, Gómez-Vallejo V, Meijer J, Zilberfain C, Estrela-Lopis I, Baz Z, Cossío U, Llop J: Gold Nanoparticles as Boron Carriers for Boron Neutron Capture Therapy: Synthesis, Radiolabelling and In Vivo Evaluation. Molecules 2019, 24(19):3609.
  333. Pyo A, Kim HS, Kim HS, Yun M, Kim D-Y, Min J-J: N-(2-(Dimethylamino) Ethyl)-4-18F-Fluorobenzamide: A Novel Molecular Probe for High-Contrast PET Imaging of Malignant Melanoma. Journal of Nuclear Medicine 2019, 60(7):924-929.
  334. Qiao L, Fisher E, McMurray L, Milicevic Sephton S, Hird M, Kuzhuppilly-Ramakrishnan N, Williamson DJ, Zhou X, Werry E, Kassiou M: Radiosynthesis of (R, S)-[18F] GE387: A Potential PET Radiotracer for Imaging Translocator Protein 18 kDa (TSPO) with Low Binding Sensitivity to the Human Gene Polymorphism rs6971. ChemMedChem 2019, 14(9):982-993.
  335. Qin C, Shao F, Hu F, Song W, Song Y, Guo J, Lan X: 18 F-FDG PET/CT in diagnostic and prognostic evaluation of patients with cardiac masses: a retrospective study. European Journal of Nuclear Medicine and Molecular Imaging 2019:1-11.
  336. QUELVEN I, Monteil J, Sage M, Saidi A, Mounier J, Bayout A, Garrier J, Cogne M, Durand-Panteix S: 212Pb Alpha-Radioimmunotherapy targeting CD38 in Multiple Myeloma: a preclinical study. Journal of Nuclear Medicine 2019:jnumed. 119.239491.
  337. Quevenco FC, Schreiner SJ, Preti MG, van Bergen J, Kirchner T, Wyss M, Steininger SC, Gietl A, Leh SE, Buck A: GABA and glutamate moderate beta-amyloid related functional connectivity in cognitively unimpaired old-aged adults. NeuroImage: Clinical 2019, 22:101776.
  338. Radaram B, Pisaneschi F, Rao Y, Yang P, Piwnica-Worms D, Alauddin MM: Novel derivatives of anaplastic lymphoma kinase inhibitors: Synthesis, radiolabeling, and preliminary biological studies of fluoroethyl analogues of crizotinib, alectinib, and ceritinib. European journal of medicinal chemistry 2019, 182:111571.
  339. Raychaudhuri S, Abria C, Harmany ZT, Smith CM, Kundu-Raychaudhuri S, Raychaudhuri SP, Chaudhari AJ: Quantitative tracking of inflammatory activity at the peak and trough plasma levels of tofacitinib, a Janus kinase inhibitor, via in vivo 18F-FDG PET. International journal of rheumatic diseases 2019.
  340. Real CC, Doorduin J, Kopschina Feltes P, Vállez García D, de Paula Faria D, Britto LR, de Vries EF: Evaluation of exercise-induced modulation of glial activation and dopaminergic damage in a rat model of Parkinson’s disease using [11C] PBR28 and [18F] FDOPA PET. Journal of Cerebral Blood Flow & Metabolism 2019, 39(6):989-1004.
  341. Reilly SW, Puentes LN, Schmitz A, Hsieh C-J, Weng C-C, Hou C, Li S, Kuo Y-M, Padakanti P, Lee H: Synthesis and evaluation of an AZD2461 [18F] PET probe in non-human primates reveals the PARP-1 inhibitor to be non-blood-brain barrier penetrant. Bioorganic chemistry 2019, 83:242-249.
  342. Reisinger SN, Wanek T, Langer O, Pollak DD: PET imaging of the mouse brain reveals a dynamic regulation of SERT density in a chronic stress model. Translational psychiatry 2019, 9(1):80.
  343. Ren Q, Mohri K, Warashina S, Wada Y, Watanabe Y, Mukai H: Improved immuno-PET imaging of HER2-positive tumors in mice: Urokinase injection-triggered clearance enhancement of 64Cu-trastuzumab. Molecular pharmaceutics 2019, 16(3):1065-1073.
  344. Rezaei A, Schramm G, Willekens SM, Delso G, Van Laere K, Nuyts J: A Quantitative Evaluation of Joint Activity and Attenuation Reconstruction in TOF-PET/MR Brain Imaging. Journal of Nuclear Medicine 2019, 60(11):jnumed. 118.220871.
  345. Richter N, Nellessen N, Dronse J, Dillen K, Jacobs HI, Langen K-J, Dietlein M, Kracht L, Neumaier B, Fink GR: Spatial distributions of cholinergic impairment and neuronal hypometabolism differ in MCI due to AD. NeuroImage: Clinical 2019, 24:101978.
  346. Ricobaraza A, Mora-Jimenez L, Puerta E, Sanchez-Carpintero R, Mingorance A, Artieda J, Nicolas MJ, Besne G, Bunuales M, Gonzalez-Aparicio M: Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation. Scientific reports 2019, 9(1):1-15.
  347. Ritawidya R, Wenzel B, Teodoro R, Toussaint M, Kranz M, Deuther-Conrad W, Dukic-Stefanovic S, Ludwig F-A, Scheunemann M, Brust P: Radiosynthesis and Biological Investigation of a Novel Fluorine-18 Labeled Benzoimidazotriazine-Based Radioligand for the Imaging of Phosphodiesterase 2A with Positron Emission Tomography. Molecules 2019, 24(22):4149.
  348. Rivera-Marrero S, Fernández-Maza L, León-Chaviano S, Sablón-Carrazana M, Bencomo-Martínez A, Perera-Pintado A, Prats-Capote A, Zoppolo F, Kreimerman I, Pardo T: [18F] Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, In Silico, In vitro and In vivo Evaluations. Current radiopharmaceuticals 2019, 12(1):58-71.
  349. Román M, López I, Guruceaga E, Baraibar I, Ecay M, Collantes M, Nadal E, Vallejo A, Cadenas S, Echavarri-de Miguel M: Inhibitor of Differentiation-1 Sustains Mutant KRAS-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network. Cancer research 2019, 79(3):625-638.
  350. Rosestedt M, Andersson KG, Rinne SS, Leitao CD, Mitran B, Vorobyeva A, Ståhl S, Löfblom J, Tolmachev V, Orlova A: Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of hepatic uptake. Scientific reports 2019, 9(1):6779.
  351. Rubinstein E, Salhov M, Nidam-Leshem M, White V, Golan S, Baniel J, Bernstine H, Groshar D, Averbuch A: Unsupervised tumor detection in Dynamic PET/CT imaging of the prostate. Medical image analysis 2019, 55:27-40.
  352. Rudisile S, Gosewisch A, Wenter V, Unterrainer M, Böning G, Gildehaus F, Fendler W, Auernhammer C, Spitzweg C, Bartenstein P: Salvage PRRT with 177 Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival. BMC cancer 2019, 19(1):1-9.
  353. Sacher C, Blume T, Beyer L, Peters F, Eckenweber F, Sgobio C, Deussing M, Albert NL, Unterrainer M, Lindner S: Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse Model. Journal of Nuclear Medicine 2019, 60(12):1787-1793.
  354. Sachpekidis C, Karampinis I, Jakob J, Kasper B, Nowak K, Pilz L, Attenberger U, Gaiser T, Derigs H-G, Schwarzbach M: Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic 18F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group. Cancers 2019, 11(6):790.
  355. Sachpekidis C, Kopp-Schneider A, Hakim-Meibodi L, Dimitrakopoulou-Strauss A, Hassel JC: 18F-FDG PET/CT longitudinal studies in patients with advanced metastatic melanoma for response evaluation of combination treatment with vemurafenib and ipilimumab. Melanoma research 2019, 29(2):178-186.
  356. Sah B-R, Sommerauer M, Mu L, Gonzalez GP, Geistlich S, Treyer V, Schibli R, Buck A, Warnock G, Ametamey SM: Radiation dosimetry of [18 F]-PSS232—a PET radioligand for imaging mGlu5 receptors in humans. EJNMMI research 2019, 9(1):56.
  357. Sakai K, Passioura T, Sato H, Ito K, Furuhashi H, Umitsu M, Takagi J, Kato Y, Mukai H, Warashina S: Macrocyclic peptide-based inhibition and imaging of hepatocyte growth factor. Nature chemical biology 2019, 15(6):598.
  358. Salerno M, Ferrer E, Wei S, Li X, Gao W, Ouellette D, Balanoff A, Vaska P: Behavioral neuroimaging in birds using PET. Journal of neuroscience methods 2019, 317:157-164.
  359. Sandiego CM, Barret O, Lee H, Alagille D, Amenta A, Fowles K, Holden D, Seibyl JP, Tamagnan G: Imaging histamine H3 receptors with [18F] FMH3: Test–retest and occupancy studies in the non-human primate. Synapse 2019, 73(7):e22096.
  360. Sarnyai Z, Nagy K, Patay G, Molnár M, Rosenqvist G, Tóth M, Takano A, Gulyás B, Major P, Halldin C: Performance Evaluation of a High-Resolution Nonhuman Primate PET/CT System. Journal of Nuclear Medicine 2019, 60(12):1818-1824.
  361. Satoh Y, Sekine T, Omiya Y, Onishi H, Motosugi U: Reduction of the fluorine-18-labeled fluorodeoxyglucose dose for clinically dedicated breast positron emission tomography. EJNMMI physics 2019, 6(1):1-11.
  362. Schiano C, Franzese M, Pane K, Garbino N, Soricelli A, Salvatore M, de Nigris F, Napoli C: Hybrid 18F-FDG-PET/MRI Measurement of Standardized Uptake Value Coupled with Yin Yang 1 Signature in Metastatic Breast Cancer. A Preliminary Study. Cancers 2019, 11(10):1444.
  363. Schiller F, Frings L, Thurow J, Meyer PT, Mix M: Limits for reduction of acquisition time or administered activity in 18F-FDG PET studies in Alzheimer’s and frontotemporal dementia. Journal of Nuclear Medicine 2019:jnumed. 119.227132.
  364. Schinke C, Hesse S, Rullmann M, Becker G-A, Luthardt J, Zientek F, Patt M, Stoppe M, Schmidt E, Meyer K: Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls. Stress 2019, 22(1):93-102.
  365. Schneider D, Oskamp A, Holschbach M, Neumaier B, Bier D, Bauer A: Influence of binding affinity and blood plasma level on cerebral pharmacokinetics and PET imaging characteristics of two novel xanthine PET radioligands for the A1 adenosine receptor. Nuclear Medicine and Biology 2019, 82-83:1-8.
  366. Schönecker S, Brendel M, Palleis C, Beyer L, Höglinger GU, Schuh E, Rauchmann B-S, Sauerbeck J, Rohrer G, Sonnenfeld S: PET imaging of astrogliosis and tau facilitates diagnosis of parkinsonian syndromes. Frontiers in aging neuroscience 2019, 11:249.
  367. Schramm G, Koole M, Willekens S, Rezaei A, Van Weehaeghe D, Delso G, Peeters R, Mertens N, Nuyts J, Van Laere K: Regional accuracy of ZTE-based attenuation correction in static [18 F] FDG and dynamic [18 F] PE2I brain PET/MR. Frontiers in Physics 2019, 7:211.
  368. Seifert P, Winkens T, Knichel L, Kühnel C, Freesmeyer M: Stitching of 3D ultrasound datasets for the determination of large thyroid volumes–phantom study part II: mechanically-swept probes. Medical ultrasonography 2019, 21(4):389-398.
  369. Seifert P, Winkens T, Kühnel C, Gühne F, Freesmeyer M: I-124-PET/US Fusion Imaging in Comparison to Conventional Diagnostics and Tc-99m Pertechnetate SPECT/US Fusion Imaging for the Function Assessment of Thyroid Nodules. Ultrasound in medicine & biology 2019, 45(9):2298-2308.
  370. Serrano ME, Becker G, Bahri MA, Seret A, Mestdagh N, Mercier J, Mievis F, Giacomelli F, Lemaire C, Salmon E: Evaluating the In Vivo Specificity of [18F] UCB-H for the SV2A Protein, Compared with SV2B and SV2C in Rats Using microPET. Molecules 2019, 24(9):1705.
  371. Servaes S, Kara F, Glorie D, Stroobants S, Van Der Linden A, Staelens S: In Vivo Preclinical Molecular Imaging of Repeated Exposure to an N-methyl-d-aspartate Antagonist and a Glutaminase Inhibitor as Potential Glutamatergic Modulators. J Pharmacol Exp Ther 2019, 368(3):382-390.
  372. Shin S, Kim K, Lee JM, Kim E-J, Kim S-J, Kim IJ, Pak K, Lee MJ: Effect of Single-Nucleotide Polymorphisms on Decline of Dopamine Transporter Availability in Parkinson’s Disease. Journal of Clinical Neurology 2019, 15(1):102-107.
  373. Shin S, Kim K, Pak K, Nam H-Y, Kim S-J, Kim IJ: Effects of Maturation on Striatal Dopamine Transporter Availability in Rats. Nuklearmedizin 2019, 58(05):395-400.
  374. Shinotoh H, Shimada H, Kokubo Y, Tagai K, Niwa F, Kitamura S, Endo H, Ono M, Kimura Y, Hirano S: Tau imaging detects distinctive distribution of tau pathology in ALS/PDC on the Kii Peninsula. Neurology 2019, 92(2):e136-e147.
  375. Sigurdardottir H, Kranz G, Rami-Mark C, James G, Vanicek T, Gryglewski G, Berroterán-Infante N, Kautzky A, Hienert M, Traub-Weidinger T: Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity–impulsivity symptoms in ADHD measured with PET. Molecular psychiatry 2019:1-10.
  376. Singhal T, O’Connor K, Dubey S, Pan H, Chu R, Hurwitz S, Cicero S, Tauhid S, Silbersweig D, Stern E: Gray matter microglial activation in relapsing vs progressive MS: A [F-18] PBR06-PET study. Neurology-Neuroimmunology Neuroinflammation 2019, 6(5):e587.
  377. Sinharay S, Tu T-W, Kovacs ZI, Schreiber-Stainthorp W, Sundby M, Zhang X, Papadakis GZ, Reid WC, Frank JA, Hammoud DA: In vivo imaging of sterile microglial activation in rat brain after disrupting the blood-brain barrier with pulsed focused ultrasound:[18F] DPA-714 PET study. Journal of neuroinflammation 2019, 16(1):155.
  378. Smith CT, Dang LC, Burgess LL, Perkins SF, San Juan MD, Smith DK, Cowan RL, Le NT, Kessler RM, Samanez-Larkin GR: Lack of consistent sex differences in d-amphetamine-induced dopamine release measured with [18 F] fallypride PET. Psychopharmacology 2019, 236(2):581-590.
  379. Smith R, Schöll M, Leuzy A, Jögi J, Ohlsson T, Strandberg O, Hansson O: Head-to-head comparison of tau positron emission tomography tracers [18 F] flortaucipir and [18 F] RO948. European journal of nuclear medicine and molecular imaging 2019:1-13.
  380. Smith R, Wibom M, Pawlik D, Englund E, Hansson O: Correlation of in vivo [18F] Flortaucipir with postmortem Alzheimer disease tau pathology. JAMA neurology 2019, 76(3):310-317.
  381. Socan A, Petrik M, Peitl PK, Krošelj M, Rangger C, Novy Z, Svajger U, Gmeiner T, Decristoforo C: Novel cell labelling method for PET. Nuclear Medicine and Biology 2019.
  382. Socan A, Petrik M, Peitl PK, Krošelj M, Rangger C, Novy Z, Svajger U, Gmeiner T, Decristoforo C: On-cartridge preparation and evaluation of 68Ga-, 89Zr-and 64Cu-precursors for cell radiolabelling. Nuclear medicine and biology 2019, 71:23-31.
  383. Sorci O, Batzdorf AS, Mayer M, Rhodes S, Peng M, Jankelovits AR, Hornyak JN, Gerke O, Høilund-Carlsen PF, Alavi A: 18 F-sodium fluoride PET/CT provides prognostic clarity compared to calcium and Framingham risk scoring when addressing whole-heart arterial calcification. European journal of nuclear medicine and molecular imaging 2019:1-10.
  384. Spagnolo PA, Kimes A, Schwandt ML, Shokri-Kojori E, Thada S, Phillips KA, Diazgranados N, Preston KL, Herscovitch P, Tomasi D: Striatal Dopamine Release in response to Morphine: a [11C]-raclopride positron emission tomography study in Healthy Men. Biological Psychiatry 2019, 86(5):356-364.
  385. Sridharan S, Raffel J, Nandoskar A, Record C, Brooks DJ, Owen D, Sharp D, Muraro PA, Gunn R, Nicholas R: Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18 F] GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter. Molecular Imaging and Biology 2019:1-10.
  386. Stegmayr C, Stoffels G, Kops ER, Lohmann P, Galldiks N, Shah NJ, Neumaier B, Langen K-J: Influence of Dexamethasone on O-(2-[18 F]-Fluoroethyl)-l-Tyrosine Uptake in the Human Brain and Quantification of Tumor Uptake. Molecular Imaging and Biology 2019, 21(1):168-174.
  387. Steimle A, Michaelis L, Di Lorenzo F, Kliem T, Münzner T, Maerz JK, Schäfer A, Lange A, Parusel R, Gronbach K: Weak Agonistic LPS Restores Intestinal Immune Homeostasis. Molecular Therapy 2019, 27(11):1974-1991.
  388. Steinemann G, Dittmer A, Schmidt J, Josuttis D, Fähling M, Biersack B, Beindorff N, Koziolek EJ, Schobert R, Brenner W: Antitumor and antiangiogenic activity of the novel chimeric inhibitor animacroxam in testicular germ cell cancer. Molecular oncology 2019, 13(12):2679-2696.
  389. Stenzel J, Rühlmann C, Lindner T, Polei S, Teipel S, Kurth J, Rominger A, Krause B, Vollmar B, Kuhla A: [18F]-florbetaben PET/CT Imaging in the Alzheimer’s Disease Mouse Model APPswe/PS1dE9. Current Alzheimer Research 2019, 16(1):49-55.
  390. Stergiou N, Nagel J, Pektor S, Heimes A-S, Jäkel J, Brenner W, Schmidt M, Miederer M, Kunz H, Roesch F: Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer. International journal of medical sciences 2019, 16(9):1188.
  391. Stieb S, Riesterer O, Boss A, Weiss T, Guckenberger M, Özbay PS, Nanz D, Rossi C: Dependency of the blood oxygen level dependent-response to hyperoxic challenges on the order of gas administration in intracranial malignancies. Neuroradiology 2019, 61(7):1-11.
  392. Stokholm MG, Iranzo A, Østergaard K, Serradell M, Otto M, Svendsen KB, Garrido A, Vilas D, Fedorova TD, Santamaria J: Cholinergic denervation in idiopathic rapid eye movement sleep behaviour disorder patients. European journal of neurology 2019.
  393. Suchacki KJ, Tavares AA, Mattiucci D, Scheller EL, Papanastasiou G, Gray C, Sinton MC, Ramage LE, McDougald WA, Lovdel A: Bone marrow adipose tissue is a unique adipose subtype with distinct roles in systemic glucose homeostasis. bioRxiv 2019:673129.
  394. Sugyo A, Aung W, Tsuji AB, Sudo H, Takashima H, Yasunaga M, Matsumura Y, Saga T, Higashi T: Anti‑tissue factor antibody‑mediated immuno‑SPECT imaging of tissue factor expression in mouse models of pancreatic cancer. Oncology reports 2019, 41(4):2371-2378.
  395. Sundar LK, Muzik O, Rischka L, Hahn A, Rausch I, Lanzenberger R, Hienert M, Klebermass E-M, Füchsel F-G, Hacker M: Towards quantitative [18F] FDG-PET/MRI of the brain: Automated MR-driven calculation of an image-derived input function for the non-invasive determination of cerebral glucose metabolic rates. Journal of Cerebral Blood Flow & Metabolism 2019, 39(8):1516-1530.
  396. Svoboda J, Litvinec A, Kala D, Pošusta A, Vávrová L, Jiruška P, Otáhal J: Strain Differences in Intraluminal Thread Model of Middle Cerebral Artery Occlusion in Rats. Physiological research 2019, 68(1):37-48.
  397. Tai YC, Chi MH, Chu C-L, Chiu NT, Yao WJ, Chen PS, Yang YK: Availability of striatal dopamine transporter in healthy individuals with and without a family history of ADHD. Journal of attention disorders 2019, 23(7):665-670.
  398. Takamura Y, Shibahara O, Watanabe M, Fujihara M, Yamada S, Akehi M, Sasaki T, Hirano H, Kakuta H: Fluorine-18 (18F)-labeled Retinoid X Receptor (RXR) Partial Agonist whose Tissue Transferability is Affected by Other RXR Ligands. Bioorganic & Medicinal Chemistry 2019.
  399. Takano A, Chen L, Nag S, Brodney MA, Arakawa R, Chang C, Amini N, Doran SD, Dutra JK, McCarthy TJ: Quantitative Analysis of 18F-PF-06684511, a Novel PET Radioligand for Selective β-Secretase 1 Imaging, in Nonhuman Primate Brain. Journal of Nuclear Medicine 2019, 60(7):992-997.
  400. Takeuchi J, Kikukawa T, Saito H, Hasegawa I, Takeda A, Hatsuta H, Kawabe J, Wada Y, Mawatari A, Igesaka A: Amyloid-Negative Dementia in the Elderly is Associated with High Accumulation of Tau in the Temporal Lobes. The Open Biomedical Engineering Journal 2019, 13(1).
  401. Tang D, Li J, Nickels ML, Huang G, Cohen AS, Manning HC: Preclinical Evaluation of a Novel TSPO PET Ligand 2-(7-Butyl-2-(4-(2-[18 F] Fluoroethoxy) phenyl)-5-Methylpyrazolo [1, 5-a] Pyrimidin-3-yl)-N, N-Diethylacetamide (18 F-VUIIS1018A) to Image Glioma. Molecular Imaging and Biology 2019, 21(1):113-121.
  402. Tang J, Yang B, Adams MP, Shenkov NN, Klyuzhin IS, Fotouhi S, Davoodi-Bojd E, Lu L, Soltanian-Zadeh H, Sossi V: Artificial Neural Network–Based Prediction of Outcome in Parkinson’s Disease Patients Using DaTscan SPECT Imaging Features. Molecular Imaging and Biology 2019:1-9.
  403. Terada T, Yokokura M, Obi T, Bunai T, Yoshikawa E, Ando I, Shimada H, Suhara T, Higuchi M, Ouchi Y: In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer’s disease. Journal of neurology 2019:1-11.
  404. Thapa N, Jeong Y-J, Kang H, Choi G-E, Yoon H-J, Kang D-Y: A Comparative Study of [F-18] Florbetaben (FBB) PET Imaging, Pathology, and Cognition between Normal and Alzheimer Transgenic Mice. Biomedical Science Letters 2019, 25(1):7-14.
  405. Thomas E, Menon JU, Owen J, Skaripa-Koukelli I, Wallington S, Gray M, Mannaris C, Kersemans V, Allen D, Kinchesh P: Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy. Theranostics 2019, 9(19):5595.
  406. Thomsen MK, Skouboe MK, Boularan C, Vernejoul F, Lioux T, Leknes SL, Berthelsen MF, Riedel M, Cai H, Joseph JV: The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma. Oncogene 2019:1-13.
  407. Thonglim P, Chotipanich C, Buranasiri P: Optimized uptake time of 18F-THK5351 PET/CT in normal Thai brain. Journal of Physics Communications 2019, 3(7):075011.
  408. Thonglim P, Chotipanich C, Iamsa-art C, Jantarato A, Buranasiri P: Surface of quantitative uptake value of radiopharmaceutical PET/CT in normal Thai population. In: Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems XVII: 2019: International Society for Optics and Photonics; 2019: 108681I.
  409. Tible M, Mouton Liger F, Schmitt J, Giralt A, Farid K, Thomasseau S, Gourmaud S, Paquet C, Rondi Reig L, Meurs E: PKR knockout in the 5xFAD model of Alzheimer’s disease reveals beneficial effects on spatial memory and brain lesions. Aging cell 2019, 18(3):e12887.
  410. Tiepolt S, Luthardt J, Patt M, Hesse S, Hoffmann KT, Weise D, Gertz HJ, Barthel H: Early after Administration [11C] PiB PET Images Correlate with Cognitive Dysfunction Measured by the CERAD Test Battery. Journal of Alzheimer’s Disease 2019, 68(Preprint):1-12.
  411. Tjörnstrand A, Casar-Borota O, Heurling K, Schöll M, Gjertsson P, Himmelman J, Itsenko O, Ragnarsson O, Nyström HF: Lower 68Ga-DOTATOC Uptake in Non-Functioning Pituitary Neuroendocrine Tumors Compared to Normal Pituitary Gland–a Proof-of-Concept Study. Clinical Endocrinology 2019.
  412. Tobey H, Lucas T, Bledsoe D, Mykins M, Campbell C, Berr SS, Sasser T, Helm R, Brolinson P, Klein B: Effect of Osteopathic Cranial Manipulative Medicine on an Aged Rat Model of Alzheimer Disease. The Journal of the American Osteopathic Association 2019, 119(11):713.
  413. Tobon G, Hesterman J, Patel S, Lackas C: High-Level Story: Data Analysis in Multimodal Preclinical Imaging—Methods and Tools. In: Image Fusion in Preclinical Applications. edn.: Springer; 2019: 1-24.
  414. Toledano M, Gutierrez-Pérez JL, Gutierrez-Corrales A, Serrera-Figallo MA, Toledano-Osorio M, Rosales-Leal JI, Aguilar M, Osorio R, Torres-Lagares D: Novel non-resorbable polymeric-nanostructured scaffolds for guided bone regeneration. Clinical oral investigations 2019:1-13.
  415. Tollefson S, Gertler J, Himes ML, Paris J, Kendro S, Lopresti B, Scott Mason N, Narendran R: Imaging phosphodiesterase-10a availability in cocaine use disorder with [11C] IMA107 and PET. Synapse 2019, 73(1):e22070.
  416. Tomadesso C, Gonneaud J, Egret S, Perrotin A, Pélerin A, de Flores R, de la Sayette V, Desgranges B, Chételat G, La Joie R: Is there a specific memory signature associated with Aβ-PET positivity in patients with amnestic mild cognitive impairment? Neurobiology of aging 2019, 77:94-103.
  417. Tomasi DG, Wiers CE, Shokri-Kojori E, Zehra A, Ramirez V, Freeman C, Burns J, Kure Liu C, Manza P, Kim SW: Association Between Reduced Brain Glucose Metabolism and Cortical Thickness in Alcoholics: Evidence of Neurotoxicity. International Journal of Neuropsychopharmacology 2019, 22(9):548-559.
  418. Tool K: Positron Emission Tomography. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease: A Focus on Early Phase Clinical Drug Development 2019:191.
  419. Tournier BB, Tsartsalis S, Ceyzériat K, Medina Z, Fraser BH, Grégoire M-C, Kövari E, Millet P: Fluorescence-activated cell sorting to reveal the cell origin of radioligand binding. Journal of Cerebral Blood Flow & Metabolism 2019:0271678X19860408.
  420. Tournier N, Bauer M, Pichler V, Nics L, Klebermass E-M, Bamminger K, Matzneller P, Weber M, Karch R, Caille F: Impact of P-glycoprotein Function on the Brain Kinetics of the Weak Substrate 11C-Metoclopramide Assessed with PET Imaging in Humans. Journal of Nuclear Medicine 2019, 60(7):jnumed. 118.219972.
  421. Toyohara J, Yamamoto H, Tago T: Searching for diagnostic properties of novel fluorine-18-labeled d-allose. Annals of nuclear medicine 2019, 33(11):855-865.
  422. Tran VH, Park H, Park J, Kwon Y-D, Kang S, Jung JH, Chang K-A, Lee BC, Lee S-Y, Kang S: Synthesis and evaluation of novel potent TSPO PET ligands with 2-phenylpyrazolo [1, 5-a] pyrimidin-3-yl acetamide. Bioorganic & medicinal chemistry 2019, 27(18):4069-4080.
  423. Truong VA, Hsu M-N, Nguyen K, Thi N, Lin M-W, Shen C-C, Lin C-Y, Hu Y-C: CRISPRai for simultaneous gene activation and inhibition to promote stem cell chondrogenesis and calvarial bone regeneration. Nucleic acids research 2019, 47(13):e74.
  424. Tsai H-H, Pasi M, Tsai L-K, Chen Y-F, Lee B-C, Tang S-C, Fotiadis P, Huang C-Y, Yen R-F, Jeng J-S: Microangiopathy underlying mixed-location intracerebral hemorrhages/microbleeds: A PiB-PET study. Neurology 2019, 92(8):e774-e781.
  425. Tsai S-Y, Wu Y-W, Wang S-Y, Shiau Y-C, Chiu K-M, Tsai H-Y, Lee C-L, Hsu J-C, Tu C-M, Lin H-H: Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction. European journal of nuclear medicine and molecular imaging 2019, 46(12):2601-2609.
  426. Tseng J-R, Chang Y-H, Yang L-Y, Wu C-T, Chen S-Y, Wan C-H, Hsiao T, Yen T-C: Potential usefulness of 68 Ga-citrate PET/CT in detecting infected lower limb prostheses. EJNMMI research 2019, 9(1):2.
  427. Tsukada H: PET Imaging of Mitochondrial Function in the Living Brain. In: Mitochondrial and Brain Disorders. edn.: IntechOpen; 2019.
  428. Tuura ROG, Warnock G, Ametamey S, Treyer V, Noeske R, Buck A, Sommerauer M: Imaging glutamate redistribution after acute N-acetylcysteine administration: A simultaneous PET/MR study. NeuroImage 2019, 184:826-833.
  429. Ulke C, Rullmann M, Huang J, Luthardt J, Becker G-A, Patt M, Meyer PM, Tiepolt S, Hesse S, Sabri O: Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S, S)-O-[11 C] methylreboxetine positron emission tomography study. Translational psychiatry 2019, 9(1):1-10.
  430. Unterrainer M, Fleischmann D, Diekmann C, Vomacka L, Lindner S, Vettermann F, Brendel M, Wenter V, Ertl-Wagner B, Herms J: Comparison of 18 F-GE-180 and dynamic 18 F-FET PET in high grade glioma: a double-tracer pilot study. European journal of nuclear medicine and molecular imaging 2019, 46(3):580-590.
  431. Vainio S, Dickens A, Tuisku J, Eskola O, Solin O, Löyttyniemi E, Anthony D, Rinne J, Airas L, Haaparanta-Solin M: Cessation of anti-VLA-4 therapy in a focal rat model of multiple sclerosis causes an increase in neuroinflammation. EJNMMI research 2019, 9(1):38.
  432. Vairo C, Collantes M, Quincoces G, Villullas S, Peñuelas I, Pastor M, Gil A, Gainza E, Hernandez R, Igartua M: Preclinical safety of topically administered nanostructure lipid carriers (NLC) for wound healing application: biodistribution and toxicity studies. International journal of pharmaceutics 2019, 569:118484.
  433. Valli M, Cho SS, Masellis M, Chen R, Rusjan P, Kim J, Koshimori Y, Mihaescu A, Strafella AP: DRD2 Genotype-Based Variants Modulates D2 Receptor Distribution in Ventral Striatum. Molecular neurobiology 2019, 56(9):1-9.
  434. Van Camp N, Balbastre Y, Herard A-S, Lavisse S, Tauber C, Wimberley C, Guillermier M, Berniard A, Gipchtein P, Jan C: Assessment of simplified methods for quantification of [18F]-DPA-714 using 3D whole-brain TSPO immunohistochemistry in a non-human primate. Journal of Cerebral Blood Flow & Metabolism 2019:0271678X19859034.
  435. van Leyen K, Roelcke U, Gruber P, Remonda L, Berberat J: Susceptibility and Tumor Size Changes During the Time Course of Standard Treatment in Recurrent Glioblastoma. Journal of Neuroimaging 2019, 29(5):645-649.
  436. Van Weehaeghe D, Van Schoor E, De Vocht J, Koole M, Attili B, Celen S, Declercq L, Thal DR, Van Damme P, Bormans G: TSPO versus P2X7 as target for neuroinflammation–an in vitro and in vivo study. Journal of Nuclear Medicine 2019:jnumed. 119.231985.
  437. Vandergaast R, Khongwichit S, Jiang H, DeGrado TR, Peng K-W, Smith DR, Russell SJ, Suksanpaisan L: Enhanced noninvasive imaging of oncology models using the NIS reporter gene and bioluminescence imaging. Cancer gene therapy 2019:1.
  438. Vassena E, Van Opstal F, Goethals I, Verguts T: Striatal dopamine D2 binding correlates with locus of control: Preliminary evidence from [11C] raclopride Positron Emission Tomography. International Journal of Psychophysiology 2019, 146:117-124.
  439. Vega SC, Leiss V, Piekorz R, Calaminus C, Pexa K, Vuozzo M, Schmid AM, Devanathan V, Kesenheimer C, Pichler BJ: Selective protection of murine cerebral G i/o-proteins from inactivation by parenterally injected pertussis toxin. Journal of Molecular Medicine 2019:1-14.
  440. Verhoeven J, Baguet T, Piron S, Pauwelyn G, Bouckaert C, Descamps B, Raedt R, Vanhove C, De Vos F, Goethals I: 2-[18F] FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation. Nuclear Medicine and Biology 2019.
  441. Verhoeven J, Bolcaen J, De Meulenaere V, Kersemans K, Descamps B, Donche S, Van den Broecke C, Boterberg T, Kalala J-P, Deblaere K: Technical feasibility of [18 F] FET and [18 F] FAZA PET guided radiotherapy in a F98 glioblastoma rat model. Radiation Oncology 2019, 14(1):89.
  442. Verhoeven J, Hulpia F, Kersemans K, Bolcaen J, De Lombaerde S, Goeman J, Descamps B, Hallaert G, Van den Broecke C, Deblaere K: New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma. Scientific reports 2019, 9(1):2878.
  443. Vermeulen K, Ahamed M, Luyten K, Bormans G: Evaluation of [11C] KB631 as a PET tracer for in vivo visualisation of HDAC6 in B16. F10 melanoma. Nuclear medicine and biology 2019, 74:1-11.
  444. Vermeulen K, Naus E, Ahamed M, Attili B, Siemons M, Luyten K, Celen S, Schymkowitz J, Rousseau F, Bormans G: Evaluation of [11C] NMS-E973 as a PET tracer for in vivo visualisation of HSP90. Theranostics 2019, 9(2):554.
  445. Vetel S, Vercouillie J, Buron F, Vergote J, Tauber C, Busson J, Chicheri G, Routier S, Sérrière S, Chalon S: Longitudinal PET Imaging of α7 Nicotinic Acetylcholine Receptors with [18 F] ASEM in a Rat Model of Parkinson’s Disease. Molecular imaging and biology 2019:1-10.
  446. Vlachavas EI, Pilalis E, Papadodima O, Koczan D, Willis S, Klippel S, Cheng C, Pan L, Sachpekidis C, Pintzas A: Radiogenomic Analysis of F-18-Fluorodeoxyglucose Positron Emission Tomography and Gene Expression Data Elucidates the Epidemiological Complexity of Colorectal Cancer Landscape. Computational and structural biotechnology journal 2019, 17:177-185.
  447. von Hacht JL, Erdmann S, Niederstadt L, Prasad S, Wagener A, Exner S, Beindorff N, Brenner W, Grötzinger C: Increasing molar activity by HPLC purification improves 68Ga-DOTA-NAPamide tumor accumulation in a B16/F1 melanoma xenograft model. PloS one 2019, 14(6):e0217883.
  448. von Witting E, Garousi J, Lindbo S, Vorobyeva A, Altai M, Oroujeni M, Mitran B, Orlova A, Hober S, Tolmachev V: Selection of the optimal macrocyclic chelators for labeling with 111In and 68Ga improves contrast of HER2 imaging using engineered scaffold protein ADAPT6. European Journal of Pharmaceutics and Biopharmaceutics 2019, 140:109-120.
  449. Vottero GV, Morfoisse F, Durré T, Blacher S, Becker G, Bahri MA, Plenevaux A, Noel A, Nizet JL: Contralateral Vascularized Lymph Node Transfer: An Optimized Mouse Model. Journal of Reconstructive Microsurgery Open 2019, 4(02):e83-e91.
  450. Vraka C, Pichler V, Berroterán-Infante N, Wollenweber T, Pillinger A, Hohensinner M, Fetty L, Beitzke D, Li X, Philippe C: Optimization of the Automated Synthesis of [11C] mHED—Administered and Apparent Molar Activities. Pharmaceuticals 2019, 12(1):12.
  451. Vrselja Z, Daniele SG, Silbereis J, Talpo F, Morozov YM, Sousa AM, Tanaka BS, Skarica M, Pletikos M, Kaur N: Restoration of brain circulation and cellular functions hours post-mortem. Nature 2019, 568(7752):336.
  452. Wagner JM, Sichler ME, Schleicher EM, Franke TN, Irwin C, Löw MJ, Beindorff N, Bouter C, Bayer TA, Bouter Y: Analysis of motor function in the Tg4-42 mouse model of Alzheimer’s disease. Frontiers in Behavioral Neuroscience 2019, 13:107.
  453. Walker M, Kuebler L, Goehring CM, Pichler BJ, Herfert K: Imaging SERT Availability in a Rat Model of L-DOPA-Induced Dyskinesia. Molecular Imaging and Biology 2019:1-9.
  454. Wang F, Wang Z, Wang F, Dong K, Zhang J, Sun Y-j, Liu C-f, Xing M-j, Cheng X, Wei S: Comparative strategies for stem cell biodistribution in a preclinical study. Acta pharmacologica Sinica 2019:1-9.
  455. Wang H, Dong W, Zhao Q, Lu K, Guo X, Liu H, Wu Z, Li S: Synthesis of N-(6-[18F] Fluoropyridin-3-yl) glycine as a potential renal PET agent. Nuclear medicine and biology 2019, 76:21-27.
  456. Wang Y, Li A: Regulatory effects of Ningdong granule on dopaminergic and serotonergic neurotransmission in a rat model of Tourette syndrome assessed by PET. Molecular medicine reports 2019, 20(1):191-197.
  457. Wang Y, Shi Z, Zhang N, Cai L, Li Y, Yang H, Yao S, Xing X, Ji Y, Gao S: Spatial patterns of hypometabolism and amyloid deposition in variants of alzheimer’s disease corresponding to brain networks: A prospective cohort study. Molecular Imaging and Biology 2019, 21(1):140-148.
  458. Wang Z, Aguilar EG, Luna JI, Dunai C, Khuat LT, Le CT, Mirsoian A, Minnar CM, Stoffel KM, Sturgill IR: Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nature medicine 2019, 25(1):141.
  459. Watanabe S, Shiga T, Hirata K, Magota K, Okamoto S, Toyonaga T, Higashikawa K, Yasui H, Kobayashi J, Nishijima K-i: Biodistribution and radiation dosimetry of the novel hypoxia PET probe [18 F] DiFA and comparison with [18 F] FMISO. EJNMMI research 2019, 9(1):60.
  460. Weigend S, Holst SC, Treyer V, O’Gorman Tuura RL, Meier J, Ametamey SM, Buck A, Landolt H-P: Dynamic changes in cerebral and peripheral markers of glutamatergic signaling across the human sleep–wake cycle. Sleep 2019, 42(11):zsz161.
  461. Weiskirchen R, Weiskirchen S, Kim P, Winkler R: Software solutions for evaluation and visualization of laser ablation inductively coupled plasma mass spectrometry imaging (LA-ICP-MSI) data: a short overview. Journal of cheminformatics 2019, 11(1):16.
  462. Wilson TC, Xavier M-A, Knight J, Verhoog S, Torres JB, Mosley M, Hopkins SL, Wallington S, Allen PD, Kersemans V: PET Imaging of PARP Expression Using 18F-Olaparib. Journal of Nuclear Medicine 2019, 60(4):504-510.
  463. Winterdahl M, Noer O, Orlowski D, Schacht AC, Jakobsen S, Alstrup AK, Gjedde A, Landau AM: Sucrose intake lowers μ-opioid and dopamine D2/3 receptor availability in porcine brain. Scientific reports 2019, 9(1):1-11.
  464. Wolf F, Paefgen V, Winz O, Mertens M, Koch S, Gross-Weege N, Morgenroth A, Rix A, Schnoering H, Chalabi K: MR and PET-CT monitoring of tissue-engineered vascular grafts in the ovine carotid artery. Biomaterials 2019, 216:119228.
  465. Wong C-K, Chan S-C, Ng S-H, Hsieh C-H, Cheng N-M, Yen T-C, Liao C-T: Textural features on 18F-FDG PET/CT and dynamic contrast-enhanced MR imaging for predicting treatment response and survival of patients with hypopharyngeal carcinoma. Medicine 2019, 98(33):e16608.
  466. Workman CD, Kindred JH, Boles Ponto LL, Kamholz J, Rudroff T: The Effects of Chronic Δ-9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) use on Cerebral Glucose Metabolism in Multiple Sclerosis: A Pilot Study. Applied Physiology, Nutrition, and Metabolism 2019(ja).
  467. Wulkersdorfer B, Bauer M, Karch R, Stefanits H, Philippe C, Weber M, Czech T, Menet M-C, Declèves X, Hainfellner JA: Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomography. EJNMMI research 2019, 9(1):110.
  468. Xiong C, Yin D, Li J, Huang Q, Ravoori MK, Kundra V, Zhu H, Yang Z, Lu Y, Li C: Metformin Reduces Renal Uptake of Radiotracers and Protects Kidneys from Radiation-Induced Damage. Molecular pharmaceutics 2019, 16(2):808-815.
  469. Xu J-G: Evaluation of Neuropathic Pain in a Rat Model of Total Brachial Plexus Avulsion from Behavior to Brain Metabolism. Pain Physician 2019, 22:E215-E224.
  470. Yagi Y, Kimura H, Okuda H, Ono M, Nakamoto Y, Togashi K, Saji H: Evaluation of [18F] pitavastatin as a positron emission tomography tracer for in vivo organic transporter polypeptide function. Nuclear medicine and biology 2019, 74:25-31.
  471. Yajima S, Miyagawa S, Fukushima S, Isohashi K, Watabe T, Ikeda H, Horitsugi G, Harada A, Sakaniwa R, Hatazawa J: Microvascular Dysfunction Related to Progressive Left Ventricular Remodeling due to Chronic Occlusion of the Left Anterior Descending Artery in an Adult Porcine Heart. International heart journal 2019:18-346.
  472. Yakushiji H, Kobayashi K, Takenaka F, Kishi Y, Shinohara M, Akehi M, Sasaki T, Ohno E, Matsuura E: Novel single-chain variant of antibody against mesothelin established by phage library. Cancer science 2019, 110(9):2722-2733.
  473. Yamagishi S, Iga Y, Nakamura M, Takizawa C, Fukumoto D, Kakiuchi T, Nishiyama S, Ohba H, Tsukada H, Sato K: Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study. Journal of neuroinflammation 2019, 16(1):208.
  474. Yang K-C, Stepanov V, Amini N, Martinsson S, Takano A, Bundgaard C, Bang-Andersen B, Sanchez C, Halldin C, Farde L: Effect of clinically relevant doses of vortioxetine and citalopram on serotonergic PET markers in the nonhuman primate brain. Neuropsychopharmacology 2019, 44(10):1706-1713.
  475. Yang M, Kong DY, Chen JC: Inhibition of miR-148b ameliorates myocardial ischemia/reperfusion injury via regulation of Wnt/β-catenin signaling pathway. Journal of cellular physiology 2019.
  476. Yasuno F, Kajimoto K, Ihara M, Taguchi A, Yamamoto A, Fukuda T, Kazui H, Iida H, Nagatsuka K: Amyloid β deposition in subcortical stroke patients and effects of educational achievement: a pilot study. International journal of geriatric psychiatry 2019, 34(11):1651-1657.
  477. Yeh SH-H, Shie F-S, Liu H-K, Yao H-H, Kao P-C, Lee Y-H, Chen L-M, Hsu S-M, Chao L-J, Wu K-W: A high-sucrose diet aggravates Alzheimer’s disease pathology, attenuates hypothalamic leptin signaling, and impairs food-anticipatory activity in APPswe/PS1dE9 mice. Neurobiology of Aging 2019.
  478. Yeow YL, Kotamraju VR, Wang X, Chopra M, Azme N, Wu J, Schoep TD, Delaney DS, Feindel K, Li J: Immune-mediated ECM depletion improves tumour perfusion and payload delivery. EMBO molecular medicine 2019, 11(12):e10923.
  479. Yin L, Sun H, Zhao M, Wang A, Qiu S, Gao Y, Ding J, Ji S-J, Shi H, Gao M: Rational Design and Synthesis of a Metalloproteinase-Activatable Probe for Dual-Modality Imaging of Metastatic Lymph Nodes in Vivo. The Journal of organic chemistry 2019, 84(10):6126-6133.
  480. Yokokura M, Terada T, Bunai T, Nakaizumi K, Kato Y, Yoshikawa E, Futatsubashi M, Suzuki K, Yamasue H, Ouchi Y: Alterations in serotonin transporter and body image-related cognition in anorexia nervosa. NeuroImage: Clinical 2019, 23:101928.
  481. Yoon HJ, Jeong YJ, Kang D-Y, Kang H, Yeo KK, Jeong JE, Park KW, Choi GE, Ha S-W: Effect of Data Augmentation of F-18-Florbetaben Positron-Emission Tomography Images by Using Deep Learning Convolutional Neural Network Architecture for Amyloid Positive Patients. Journal of the Korean Physical Society 2019, 75(8):597-604.
  482. Zeissig S, Rosati E, Dowds CM, Aden K, Bethge J, Schulte B, Pan WH, Mishra N, Zuhayra M, Marx M: Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease. Gut 2019, 68(1):25-39.
  483. Zeitler B, Froelich S, Marlen K, Shivak DA, Yu Q, Li D, Pearl JR, Miller JC, Zhang L, Paschon DE: Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington’s disease. Nature medicine 2019, 25(7):1131-1142.
  484. Zhao J, Zhang Z, Nie D, Ma H, Yuan G, Su S, Liu S, Liu S, Tang G: PET Imaging of Hepatocellular Carcinomas: 18F-Fluoropropionic Acid as a Complementary Radiotracer for 18F-Fluorodeoxyglucose. Molecular imaging 2019, 18:1536012118821032.
  485. Zhao M, Liu M, Leal JP, Tsui BMW, Wong DF, Pomper MG, Zhou Y: Association of PET-measured myocardial flow reserve with echocardiography-estimated pulmonary artery systolic pressure in patients with hypertrophic cardiomyopathy. PLoS One 2019, 14(3):e0212573.
  486. Zhao Q, Liu M, Ha L, Zhou Y, Initiative AsDN: Quantitative 18F-AV1451 Brain Tau PET Imaging in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer’s Disease Patients. Frontiers in neurology 2019, 10:486.
  487. Zhao YH, Liu NW, Ke CC, Liu BW, Chen YA, Luo C, Zhang Q, Xia ZY, Liu RS: Combined treatment of sodium ferulate, n-butylidenephthalide, and ADSC s rehabilitates neurovascular unit in rats after photothrombotic stroke. Journal of cellular and molecular medicine 2019, 23(1):126-142.
  488. Zhou C, Guan XJ, Guo T, Zeng QL, Gao T, Huang PY, Xuan M, Gu QQ, Xu XJ, Zhang MM: Progressive brain atrophy in Parkinson’s disease patients who convert to mild cognitive impairment. CNS neuroscience & therapeutics 2019, 26(1):117-125.
  489. Zhu Y, Fiedler SA, Hibert ML, Wang C: Synthesis of a carbon-11 radiolabeled BACE1 inhibitor. Medicinal Chemistry Research 2019:1-6.
  490. Zorick T, Okita K, Mandelkern MA, London ED, Brody AL: Effects of Citalopram on Cue-induced Alcohol Craving and Thalamic D2/3 Dopamine Receptor Availability. International Journal of Neuropsychopharmacology 2019, 22(4):286-291.
  491. Zoufal V, Mairinger S, Brackhan M, Krohn M, Filip T, Sauberer M, Stanek J, Wanek T, Tournier N, Bauer M: Imaging P-glycoprotein Induction at the Blood-Brain Barrier of a Beta-Amyloidosis Mouse Model with 11C-Metoclopramide PET. Journal of Nuclear Medicine 2019:jnumed. 119.237198.
  492. Zoufal V, Mairinger S, Krohn M, Wanek T, Filip T, Sauberer M, Stanek J, Kuntner C, Pahnke J, Langer O: Measurement of cerebral ABCC1 transport activity in wild-type and APP/PS1-21 mice with positron emission tomography. Journal of Cerebral Blood Flow & Metabolism 2019:0271678X19854541.